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SUMMARY
In Section I various methods employed for the 
quantification of IgE are discussed and detailed accounts of 
two techniques used in this laboratory are presented.
Total serum IgE in the rat is estimated using the 
radioimmunosorbent test (RIST). This 'sandwich' technique 
employs anti-IgE coupled to paper discs, which binds to 
IgE present in samples or standards subsequently added.
A final incubation with radiolabelled anti-IgE presents 
the third layer of the 'sandwich', and radioactive counts 
in each sample are directly proportional to the concentration 
of IgE present.
Antigen specific rat IgE is measured in vivo by the 
Passive Cutaneous Anaphylaxis (PCA) test. Twenty-four 
hours after an intradermal injection of the diluted test 
serum an intravenous challenge of antigen and Evan's blue . 
dye is given. Attachment of antigen to the mast cell-bound 
IgE results in release of vasoactive compounds with ensuing 
increased vascular permeability which results in the 
appearance of a blue area at the injection site. The titre 
of the serum under test is taken as the reciprocal of the 
last dilution giving a reaction of 5 mm in diameter.
In Section II, 1, experiments are described in which 
primary and secondary IgE antibody responses were elicited 
in Hooded Lister rats by intradermal injection or oral 
administration of very small quantities of egg-albumin.
For primary responses the minimum effective dose 
was found to be 1 jig intradermally and 10 fig orally, both 
administered with an intraperitoneal injection of
B. pertussis adjuvant. In rats immunised with these doses 
even smaller quantities of antigen evoked booster responses; 
thus, 1 ng intradermally and 1 jig orally. Large primary 
doses (> 100 jig) presented by these routes were, on the 
other hand, found to be inhibitory to the production of 
booster IgE responses as was reported previously in intra­
peritoneal immunisation experiments. The results are 
discussed in relation to IgE production and regulation 
of antigen absorption through mucosal barriers.
In Section II, 2, experiments are described which 
show that the adjuvant used in initial immunisation 
influences the subsequent occurrence of enhanced responses 
induced by an antigen challenge (booster response) or 
helminth infection (potentiated response).
Although the level of the primary response was similar 
following immunisation with egg-albumin (EA) and B. pertussis 
(Bp), aluminium hydroxide (a£(0H)^) or complete Freund's 
adjuvant (CFA) as adjuvant, the booster response was inhibited 
and the potentiated response enhanced when the latter two 
adjuvants were used. A significant IgE booster response 
could only be obtained if Bp had been used in initial immunisation.
Concavalin A (Con A) could also act as an adjuvant for 
the induction of an IgE response to EA. Moreover, a 
subsequent injection of Con A was found to enhance the 
EA specific response in a manner analogous to an antigen 
induced booster response. The Con A enhancing effect 
occurred only in animals primed with EA together with 
Bp or Con A and not in animals primed with EA in a£(OH)^
or CFA. These results are discussed in relation to the
intricacies of IgE production in this model and to more 
general mechanisms of adjuvant action.
In Section II, 3, the ability of different rat 
strains to produce IgE antibody responses following 
large and small doses of antigen and infection with
N. brasiliensis has been compared.
Sprague Dawley rats responded poorly to 1 mg and 
1 jig EA, but did produce low level secondary responses.
Some degree of inhibition was evident in CFHB and Hooded 
Lister strains following immunisation with 1 mg EA, since 
secondary responses were higher following immunisation 
with 1 jig of EA. Following antigen challenge, CFY produced 
similar but low level secondary responses whether they 
had been initially immunised with a high or low dose of 
EA, even although a primary response was not detected 
after immunisation with 1 jig EA.
Elevation of total serum IgE was less marked 
following N. brasiiiensis infection in the 'poor' IgE 
responding strains, and the total serum IgE response 
was in some cases unaccompanied by potentiation of 
the EA IgE response.
The findings are discussed in relation to the 
function of regulatory mechanisms known to be operative 
in the control of IgE responses.
GENERAL INTRODUCTION
2IgE is the fifth and the roost recently discovered 
immunoglobulin, forming a distinct antibody class in man 
and a variety of animals including dog, rat, mouse, rabbit, 
monkey and guinea-pig. This immunoglobulin mediates Type I 
anaphylactic or immediate hypersensitivity reactions which, 
in man, cause allergic disorders such as hay fever and atopic 
eczema. In these conditions and in helminth infections, IgE 
is present in elevated levels.
The fundamental event in immediate hypersensitivity is 
the binding of IgE molecules to target cells which have the 
appropriate receptors on their surfaces; such target cells 
have been recognised as circulating basophils and tissue mast 
cells. The molecule binds by way of the Fc portion leaving 
2 Fab portions free to combine with allergen molecules. The 
mechanism of mediator release requires that adjacent IgE 
molecules are linked together with antigen forming a bridge. 
Following attachment of antigen a sequence of biochemical 
events is triggered off, culminating in release of active 
compounds such as histamine, serotonin, slow reacting substance 
of anaphylaxis (SRS-A) and eosinophil chemotactic factor of 
anaphylaxis (ECF-A). These chemicals exert effects on 
surrounding tissues including vasodilation and smooth muscle 
contraction, which are in turn manifested in the clinical 
symptoms of allergy.
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Discovery and Identification of IgE antibodies
Early investigators included Blackley (1893), himself a 
hay fever sufferer, who showed that the attacks could be provoked
3by the deliberate inhalation of grass pollen and also 
that localised reactions could be elicited by the contact 
of pollen grains on to abraded areas on his forearms.
This was obviously i.n contrast to the slower development 
of delayed type reactions which were cell-mediated.
Ramirez in 1919 observed there must be a humoral factor 
involved in allergies, following the accidental transfer 
of allergic sensitivity by blood transfusion between 
normal and allergic individuals. This was confirmed by 
the demonstration of passive transfer of allergic reactions 
to a normal individual by Prausnitz and Kustner (1921). 
Prausnitz sensitised sites on his forearms by an intradermal 
injection of serum from Kustner who was hypersensitive to 
fish. Twenty four hours later he challenged the same site 
with an intradermal injection of fish extract and this caused 
an erythma and weal reaction similar to that evoked directly 
on Kustner's arm by an intradermal injection of fish extract. 
This finding was subsequently extended# it being shown that 
sensitivity to other allergens could be passively transferred 
in a similar way. The 'P-K* test was used in the diagnosis 
of hay fever and allergic asthma and remained the only method 
of assay of reaginic antibodies for 40 years.
The serum constituent was investigated and although it 
was found to be similar to antibodies produced in response to 
conventional immunisation, it did not appear to form a 
precipitate nor fix complement when combined with specific
antigens in vitro. Coca and Grove (1925) coined the term 
’atopic reagin' to describe the skin sensitising factor in 
allergic serum since it was not decided at that stage to 
confer antibody status.
The general features of antibodies remained unknown
for 45 years thereafter. Eventually it became clear they
could be divided into classes depending on their immunological
properties (Franklin, 1964). Each immunoglobulin molecule
consisted of a 4-chain polypeptide structure, 2 heavy chains
and 2 light chains. IgG, IgM and IgA had been discovered by
1960, and initially it was thought that IgA might be associated
with reaginic activity (Hereman and Vaerman, 1962). However,
further studies showed that reaginic activity was due to
'impurities' in the IgA rich serum. In 1964 a myeloma carrying
a fourth antigenic determinant was found and designated IgD.
Ishizaka and co-workers (Ishizaka et al., 1966a) presented
convincing evidence against any association between IgA or IgD
with reaginic activity. Rabbits were immunised with a reagin
rich fraction from a ragweed sensitive serum and the antiserum
obtained was absorbed with normal IgG and myeloma proteins of
known immunoglobulin classes. The absorbed antiserum did not
give a precipitin band with IgG, IgM, IgA or IgD, but a Y^-precipitin
band on immunoelectrophoresis with reagin rich fraction. Moreover
131the precipitin band specifically combined I-ragweed antigen 
(Ag.E) indicating definite antibody activity and so reagin was 
designated Ye (Ishizaka et al., 1966b).
Correlation between reaginic activity and Ye was investigated 
more fully and allergic serum was fractionated by ion exchange
chromatography, gel filtration, zone elctrophoresis and 
sucrose density gradient ultracentrifugation. The distribution 
of reaginic activity, i.e. skin sensitising activity as 
- measured by the P-K reaction, paralleled that of Y*E antibody 
as measured by radioimmunodiffusion (Ishizaka et al., 1966c). 
Subsequent results demonstrated that both reaginic activity 
and /e antibody were completely precipitated by anti-E,
(Ishizaka et al., 1967c) and so Ye was identified as the carrier 
of reaginic activity. The association of reaginic activity and 
Y e was subsequently demonstrated in other reagin-allergen 
systems (Ishizaka and Ishizaka, 1968c).
IgND
Meanwhile, in Sweden in 1965, the discovery of an atypical 
myeloma ND also established the existence of a unique immuno­
globulin. A 50 year old farmer from Uppsala was admitted to 
hospital complaining of pain in the lower back and chest. A 
high red blood cell count, immature plasma cells in bone marrow 
smears, Bence-Jones protein of the lambda type in urine and a 
serum component (M) migrating in the fast region on zone electro­
phoresis were features of the analysis. The myelomatosis lacked 
all known heavy chains. Antiserum directed against the Fc portion 
of myeloma ND and antiserum to YE reagin preparation gave a single 
precipitin line of identical specificity against YE and this 
line bound radiolabelled ragweed allergen (E), (Bennich et al.,
1968). Furthermore, anti-E antiserum precipitated myeloma ND. 
Specific blocking of the P-K reaction with myeloma ND established 
a structural relationship between IgND and YE , and a new class of
human serum immunoglobulin designated IgE was proposed by
WHO in Laussane in 1968 (Bennich et al., 1968). Subsequently,
another case PS from Hanover, N. Eng., was discovered (Ogawa, et .al.
1969), from which IgE myeloma was isolated. Since then a
number of other cases have been reported - a total of 8 to
date.
Properties of IgE 
Physico-chemi cal
The physico-chemical properties were investigated after 
the discovery of the myeloma cases, IgND being the most 
extensively studied. Its sedimentation coefficient by sucrose 
density gradient ultracentrifugation was found to be 8s and
molecular weight 190,000. It travels in the fast mobility
range in electrophoretic analysis. A glycoprotein with a 
carbohydrate content of about 12%, it consists of approximately 
60 residues of hexose, 20 of N-acetylglucosamine, 6 of N-acetyl- 
neuramic acid and 6 of fucose (Bennich and Johansson, 1968).
Reduction with 2-mercaptoethanol and alkylation by iodo- 
acetamide, followed by fractionation through a G100 column 
reveals 2 types of polypeptide chains; 2 light and 2 heavy.
The light chains have a molecular weight of 22,500 and constitute 
about 22% of the molecule; the heavy chains have a molecular
weight of 72,300 all the carbohydrate moeities being associated
with them.
Following papain digestion, the IgE molecule is split into 
Fc and Fab fragments, both considerably larger than IgG fragments 
(molecular weight 95,000 and 52,000 respectively). Antigenic
analysis of the fragments of reduced IgE reveals 2 antigenic
determinants (D) located on the heavy chain, D 1 and D_2.E E
The Fc fragment carries both determinants, D 1 at the aminoE
terminal portion, and D_2 at the carboxy end (Bennich and 
Johansson, 1971).
The Fc fragment can block the P-K reaction as effectively 
as intact IgE (ND) and it appears that the skin binding site 
is contained in the carboxy end of Fc, although the amino 
terminal end is also required in some way.
Extensive work has been carried out on the chemical 
structure of IgE (ND) by Von Bahr Lindstrom and Bennich (1974) . 
They employed various chemical reagents and proceeded to 
elucidate the peptide content of the heavy (E) and light (A) 
chains. Using cyanogen bromide to split at methionine residues, 
they deduced that the heavy chains had 7 methionine residues 
and the light chains had 1. Proceeding from the carboxy end, 
fragments were released for subsequent structural analysis 
enabling the composition of the chains to be described.
Twenty intra-chain and inter-c'nain disulphide bonds are 
present in the IgE molecule and on subjection to various reducing 
agents, these can be broken. Reductions at pH 7 in the absence 
of an unfolding agent, cleaves 8 cf the 20; final reduction takes 
20 hours in 0.1 M 2-mercaptoethanol or 4 hours in 10 mM dithioth- 
reitol (DTT). One disulphide bond links the light to the heavy 
chain and between 4 and 6 link the heavy chains (Bennich and 
Dorrington, 1973).
The antigenic characteristics of the IgE molecule were 
studied at different stages of cleavages of the disulphide 
bonds. After the reduction of 8, the decrease in antigenicity 
was 85% - as measured by the RIST, (Bennich and Johansson, 1971) , 
although with different techniques employed, the percentage 
reduction in antigenicity varied. Changes in tissue binding 
activity occurred after reduction, and at least 2 of the 8 
accessible disulphide bonds within the carboxy half of the 
heavy chain are critical for tissue binding (Stanworth et al.,1968) .
IgE is heat labile and its activity is destroyed after 
heating at 56°C for one hour. Presumably conformational changes 
are induced and the disulphide bonds in the Fc are disrupted 
(Stanworth et al., 1968). A loss in specific antigenic 
determinants was also observed although binding to allergen 
was not affected (Ishizaka et al., 1967).
Biologic and Immunologic Properties
IgE can agglutinate red cells coated with antigen and on 
the basis of antigen binding capacity, IgG and IgE have comparable 
haemagglutinating activities (Ishizaka et al., 1968c). Detection 
of complement fixation by IgE has not been found by the classical 
pathway, but non-specifically aggregated IgE molecules do fix 
complement by the alternative pathway involving factors C3 to C9. 
The Fc portion had the highest complement fixing activity and it 
appears that the structures necessary are contained in the amino 
portion of Fc, although the carboxy end plays an additional part 
(Ishizaka et al., 1972b). The importance of this late fixation 
of complement by aggregated IgE is not known.
IgE does not cross the placenta, so any IgE present in 
the foetus has been synthesised endogenously. This protects 
the offsprings of allergic mothers from becoming passively 
sensitised in utero.
Persistence and Turnover
The most characteristic feature of reaginic antibodies
is their affinity for homologous tissue. They become attached
to mast cell receptors via the Fc portion and remain there for
a considerable time. The half-life of IgE in human skin is
around 13 days (Augustin, 1967) and its presence can be detected
for up to 90 days. By contrast, Waldman (1969) found the half-
life of IgE myeloma in the circulation to be 2-3 days, as
131compared to 25 days for IgG. When I-myeloma IgE was injected 
into human and monkey skin, the protein rapidly decreased to 
about 5% of the original dose within 3-4 days, as did IgG2a. 
However, a second phase was entered and the half-life of the 
remaining IgE fell to 8.5-14 days, while IgG continued to 
disappear rapidly (Ishizaka and Ishizaka, 1971).
This indicates that two different processes are involved 
in decay of the antibodies. The initial loss phase involves 
diffusion away into the surrounding fluid and circulation. The 
second slow phase denotes the firm attachment of the IgE molecules 
on to the mast cells, which process renders them less susceptible 
to catabolism.
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Origin and Target Cells
Since circulating IgE has such a short half-life it 
suggests that it is being continuously synthesised in atopic 
individuals and that production would be greater than expected 
from normal serum levels. Tada and Ishizaka (1970) investigated 
the distribution of IgE forming cells in lymphoid tissue by the 
fluorescent antibody technique. They found tonsils and adenoids 
(removed after recurrent infection) possessed the most IgE-forming 
cells. IgE plasma cells are also predominant in bronchial and 
peritoneal lymph nodes and respiratory and gastrointestinal 
mucosae. They were scarce in spleen and subcutaneous lymph nodes 
and none were found in the lung, blood or bone marrow. From these 
investigations they put forward a possible role of locally 
synthesised IgE in allergies.
Sensitisation at the cellular level was studied by assaying 
histamine release from human leukocytes following incubation 
with anti-IgE. Normal and atopic sera were used and it was 
concluded that histamine release was a consequence of combination 
of anti-IgE with IgE on the leukocytes. A series of experiments 
provided evidence that basophil leukocytes were the target cells 
for IgE antibodies (Ishizaka et al., 1970), and it was estimated 
that each cell had in the region of 10,000-40,000 receptors 
(Ishizaka et al., 1973). Subsequent work with rat mast cells has 
given an estimate of 300,000-400,000 receptors per cell (Conrad 
et al., 1975).
IgE Levels in Normal and Disease States
The IgE level in healthy adults has been investigated in 
many laboratories (Johansson, 1968a; Gleich, Averbeck and 
Swedlund, 1971) , and has been found to be present in very 
small quantities in normal serum. The mean is in the order 
of 100-200 ng/ml, but was found to range from 100-800 ng/ml.
A research standard supplied by WHO (Rowe et al.,1970) was designated 
to contain 10,000 units where 1 unit is equivalent to 2 ngs.
IgE content of cord serum has been found to be very low, 
about 36 ng/ml (Johansson, 1968a), and even this value, on 
subsequent study, has been found to be an overestimate. This 
was probably due to a non-specific inhibiting effect of the 
high protein concentration of cord serum which had to be tested 
neat. Recent detection by Johansson and colleagues (not published) 
indicate cord serum has levels between 0 and a few ng/ml depending 
on the method used. The development of the immunoglobulin levels 
during childhood have been studied by many authors. Fig. 1 shows 
the development patterns for IgG, IgA, IgM, IgD and IgE. The 
slow rise of IgA is in sharp contrast to the fast increase of IgM.
The pattern of IgD is not so well traced, but will be easy to 
investigate by the new highly sensitive methods. In a preliminary 
study of IgE development in 50 healthy children, 6 weeks to 5 years 
of age, a rather slow increase with age was found (Johansson, 1968a). 
The difference in IgG and IgM concentrations which was found in boys 
and girls could not be shown for IgE (Berg and Johansson, 1969b).
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Fig. 1 The development during childhood of the serum 
concentrations of the five immunoglobulins. 
Data from Bennich and Johansson (1971) by 
permission of H. Bennich.
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This is of interest, since it is well known that there are 
twice as many boys as girls suffering from asthma. Adult 
levels are reached at about 10 years of age and levels 
exceeding 800 units are considered pathologically elevated.
Atopic Conditions
It has been established that the 10-20% of the population 
who have allergies, generally tend to produce more IgE than 
the normal non-allergic individuals. Significantly raised 
levels of serum IgE were found in 63% of the patients with 
extrinsic allergic asthma, and 5% of those with intrinsic non- 
allergic asthma (Johansson, 1967). The former had mean levels 
of 1,589 ng/ml, six times higher than in the intrinsic group 
who had levels no higher than normal people. Elevated levels 
of IgE are also observed in other conditions, e.g. hay fever 
and atcpic eczema (Bennich and Johansson, 1971).
The question arose whether this elevation of IgE was due 
to a high content of specific reaginic antibodies or the 
formation of non-specific IgE protein. Studies, on atopic 
eczema have indicated that much of the increased IgE represents 
specific antibodies which can combine with common antigens as 
measured by the RAST (Hoffman et al., 1975; Gleich and Jacob, 
1975) .
The level in an atopic person may fluctuate: the IgE
level increases following exposure to allergen and pollen 
allergic patients had much higher levels of IgE during the 
pollen season (Berg and Johansson, 1969a). Also, the more 
allergens a person is hypersensitive to the higher is the 
serum level of IgE.
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Non-Allergic Diseases
Increased production of IgE in helminth infection is now 
a feature of great interest. It has been found that virtually 
all helminth infections give rise to elevated levels of IgE.
Studies on Ethiopian children revealed high IgE levels 
(Johansson et al., 1968c). Those with stools positive for 
Ascaris lumbricoides had a mean serum IgE level of 4,400 ng/ml, 
those that were negative had 860 ng/ml. Similar increased 
production of IgE has been reported in infestation caused by 
Toxocara canis (Hogarth-Scott et al., 1969) and the roundworm
C. philippinensis (Rosenberg et al., 1971). Other helminth 
infections inducing raised IgE levels are schistisomiasis and 
ancylostomiasis (Bennich and Johansson, 1971) and echinococcosis 
(Huldt et al., 1973) . Live worm parasites appear to provide a 
strong stimulus for the increased biosynthesis of circulating IgE.
Other non-atopic conditions in which IgE levels are raised 
include Wiskott-Aldrich syndrome (Berglund et al., 1968). Patients 
with this disease are very susceptible to infections, thrombo­
cytopenia and eczema. The IgE level correlates with the state of 
eczema; when the latter heals spontaneously, the IgE level decreases.
The Role of Reagin
The beneficial role of IgE is not known. There is a possibility 
that it may have a protective role in helminth immunity. Clearly, 
its production in allergic individuals is not beneficial.
In Haemonchus contortus infection of sheep, Stewart (1953) 
observed that adult worms were frequently expelled (self-cure) from 
the host after reinfection with larvae. Various physical effects,
e.g. rise in blood histamine and abomasal oedema, which 
occurred following reinfection were proposed as being the 
cause of adult worm expulsion.
Nippostrongylus brasiliensis infection of laboratory 
provides a natural host-parasite relationship where a well- 
defined "self-cure" occurs around day 10 after infection 
(Jarrett et al♦, 1968a) . The rats become hypersensitive to 
N. brasiliensis antigen - this being manifest by the 
occurrence of skin reactions following intradermal injection 
or anaphylactic shock following intravenous injection of 
worm antigen (Urquhart et al., 1965). The main shock organ 
in the rat is the gut (Sanyal and West, 195 8) and in 
experimental infection a lesion occurs at the site of worm 
accumulation in the gut which resembles that produced by 
systemic anaphylaxis (Urquhart et al., 1965; Barth et al., 
1966). Also mast cells increase in number significantly in 
the lamina propria (Miller and Jarrett, 1971) and discharge 
their contents (Murray, 1972).
The inference that has been drawn from these events is 
that IgE on the mast cells combines with the worm antigen 
and leads to mast cell degranulation and subsequent leakage 
of proteins into the gut lumen. A possible useful purpose 
of this leak lesion would be to facilitate the passage of 
circulating or locally produced anti-worm antibody into 
the lumen where it would come into direct contact with the 
worms (Urquhart et al., 1965; Barth et al., 1966; Murray, 
1972). Worm expulsion has been shown to occur earlier if 
IgG anti-worm antibodies (which damage the worm enzymes) and
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the leak lesion are artificially provided in infected rats 
before they would normally be formed, and so a definite 
connection can be shown between the lesion formation and 
the worm expulsion, at least in the experimental situation.
Some Features of Reaqin Formation
Application of the RAST has revealed that the reaginic 
antibody titre in the serum of hay fever patients fluctuated 
with the changes of the season (Wide and Porath, 1966). The 
level was constant for most of the year but towards the end 
and after the pollen season the concentration increased.
Inhalation of a minute dose of ragweed pollen gave rise to 
a secondary response.
In experimental animals, early studies on artificial 
immunisation of Wistar rats demonstrated reagin formation, 
but the response was of low titre, transient and could not 
be boosted (Mota, 1964, 1967). By contrast, in rats infected 
with the nematode N. brasillensls it was shown that specific 
IgE antibodies reached high levels persisting for many weeks 
and that the response could rapidly be boosted by reinfection 
(Ogilvie, 1967). Experiments by Tada and Okumura (1971) 
using standard immunisation procedures, evoked responses of 
fairly high titres, but in contrast to those occurring in 
parasite infections, these responses were transient and could not 
be boosted. Vaz and Levine (1970) andLevine and Vaz (1970) succeeded 
in producing a pattern of persistent and boosterable results 
in certain inbred strains of mice by repeated small doses of 
antigen in aluminium hydroxide gel. Jarrett and Stewart (1974)
demonstrated a long-lived primary IgE response and this 
response, provided the rats had been immunised with a small 
dose of antigen, could be boosted to high levels following 
challenge.
Such results suggest that in different strains of 
rats and mice, and following different doses of antigen, 
different populations of lymphocytes become activated.
It has now become clear that there are at least two types 
of IgE suppressor T cells. There are T cells, the suppressive 
effect of which is antigen non-specific but selective for IgE 
responses as a class (Watanabe et al., 1976; Chiorazzi et al., 
1977), and there are T cells which suppress IgE antibody 
responses to specific antigens (Tada, 1976; Ishizaka, 1976).
It is now thought that variation among strains of mice 
and rats in the capacity to form IgE responses may reflect 
the presence or absence of one or both of these suppressor 
mechanisms. Whether these regulatory effects are present in 
man remains to be determined. If they are, it could be that 
allergies arise through defective regulatory mechanisms. More 
detailed knowledge of the immunoregulatory phenomena may 
provide better insight into treatment for such disorders.
More detailed discussion on regulation will be give in Section II 
'Control of IgE Production'.
MATERIALS AND METHODS
MATERIALS AND METHODS
Most of the materials and methods are described in 
the appropriate sections. General animal handling methods 
were as follows:
Animal Maintenance
The rats were kept in plastic cages with wire tops 
and floors, suspended above sawdust-containing trays.
The cages were stacked in racks and were washed regularly.
The temperature in the animal house was constant at 
22°C and a change of air took place 12 to 15 times per hour.
The rats were fed a pelleted diet (Primrose diet 41) 
and this was used exclusively.
Anaesthetic
Rats were anaesthetised in a large jar containing 
cotton wool moistened with trichloroethylene.
Collection of Reaginic Sera
Rats were bled from the tail vein by cutting off the 
tip of the tail and manually 'milking' the tail to deliver 
the blood into a test tube. Not more than 2 ml was 
collected except terminally where the heavily anaesthetised 
rats were bled by cardiac puncture. The blood was allowed 
to clot in the test tube and serum was collected aftep 
centrifugation. The sera obtained from individual rats 
were stored separately at -20°C.
SECTION I
DETECTION AND MEASUREMENT OF TOTAL SERUM 
IgE AND ANTIBODY IgE
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INTRODUCTION
Tests for the detection and measurement of reaginic 
antibodies (IgE) are based on one of two principles. The first 
group of tests makes use of the ability of reagin to sensitise 
homologous tissue by binding to mast cells and thus to mediate 
anaphylactic reactions on subsequent encounter with allergen.
The second group, more recently developed, makes use of specific 
antiserum to IgE in in vitro radioimmunassays.
1. Detection based on passive sensitisation in_ vivo
From the pioneering studies of Prausnitz and Kustner (1921) 
emerged the classical test for the detection of allergen specific 
antibodies. Prausnitz demonstrated that sites on his forearms 
could be passively sensitised by an intradermal injection of 
serum from Kustner who was allergic to fish. Subsequent injection 
of the same sites with fish extract evoked an erythema and weal 
reaction. Passive transfer of immediate hypersensitivity to other 
allergens could be achieved in a similar way and this method of 
detecting reaginic antibodies became known as the Prausnitz and 
Kustner (P-K) test and was routinely used for many years. Briefly, 
as described more recently by Stanworth and Kuhns (1965), the 
method is as follows: 0.1 ml intradermal injections of dilutions
of test serum are given into a number of normal skin sites, e.g. 
back or forearms; a latent period of 24-72 hours is allowed to 
elapse and then the challenge with antigen is given by pricking 
in an aliquot of concentrated allergen extract to the same site;
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30 minutes later the area of weal evoked is measured. By taking 
the logarithirn of the serum dilution and plotting it against the 
mean weal area, a linear relationship is obtained. This was a 
sensitive test, however, with the recognition of the danger of 
transferring serum hepatitis and the development of ill vitro 
methods, the P-K test is now rarely used.
An essentially similar test - the Passive Cutaneous Ana­
phylaxis (PCA) test (Ovary, 1965) - is the one most commonly 
employed to titrate reaginic antibodies in experimental animals. 
Serum is injected intradermally into the shaven skin of normal 
recipients and 48-72 hours later the appropriate antigen is 
injected intravenously, together with a dye. If the serum 
contained IgE antibodies, a local anaphylactic reaction occurs 
and is delineated by extravasation of the dye at the sites of 
increased capillary permeability. The PCA titre of a serum is 
the reciprocal of the greatest dilution giving a reaction size 
larger than 5 mm. (This test will be described in greater detail 
below).
2. Detections based on passive sensitisation in vitro
A variety of tissues may be sensitised in_ vitro. These 
include contractile tissues, e.g. guinea-pig ileum or uterus 
(Dale, 1913), chopped lung fragments from human or monkey 
(Goodfriend et al., 1966) and peripheral leukocytes (Stanworth, 
1973). In these procedures serum is incubated with tissue or 
cell preparations. After suitable washings, allergen is added
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and histamine liberation is estimated by biologic assay, e.g. 
contraction of guinea-pig ileum in Schulz-Dale bath or by 
spectrofluorometric methods. These procedures however, tend 
to have certain disadvantages such as non-specific histamine 
release which reduce their reproducibility.
A technique based on the degranulation of rat mast cells 
by human IgE has been described by Korotzer, Haddad and 
Lopapa (1971) and Perelmutter et al., (1973). Equal volumes 
of allergic serum, allergen, normal rat serum and rat peritoneal 
mast cells are incubated at 37°C for 3 minutes. After washing, 
the preparation is spun and the resultant pellet stained and 
microscopically examined for degranulation. Results are expressed 
as percent of morphologically altered cells. Alternatively, 
histamine liberation may be measured and the results expressed 
in terms of the minimum concentration of allergen eliciting a 
response.
3. Tests using specific antiserum to IgE
The discovery and subsequent purification of the human IgE 
myeloma (ND), (Johansson and Bennich, 1967) led to the production 
of antiserum specific for IgE which made this second category of 
tests possible. They may be used to detect total IgE in serum or 
other body fluids, or allergen specific IgE.
a) Detection of_total_serum_IgE
The radioimmunosorbent technique (RIST) was introduced by 
Wide and Porath (1966). It enables the detection of immuno­
globulins at concentrations of 0.01 |ig/ml or 1/1000 of that
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detected by the single radial diffusion method (Mancini 
et al., 1965). This assay was modified for IgE by Johansson, 
Bennich and Wide (1968), incorporating anti-myeloma ND as 
solid phase antibodies. Antibodies specific to Fc fragment 
of myeloma ND are coupled covalently to an insoluble dextran 
derivative. The serum to be tested is applied to this and 
also an aliquot of radiolabelled myeloma ND:
125Sephadex particle Sample or standard I myeloma ND
+ + containing IgE +
Anti-IgE
The concentration in a sample or standard is measured by its
125capacity to inhibit binding of I ND to the anti-ND on the 
sephadex particle and the gamma count varies inversely with 
the concentration of IgE in the sample.
This test is commercially available as the 'Phadebas'
IgE kit by Pharmacia and is frequently used in clinical 
application.
With the introduction of solid phase antibodies, came 
the development of systems other than those based on competition 
and 'sandwich' techniques were devised using such solid phase 
reagents as fine particles of Sephadex (Johansson et al. , 1968) , 
insides of test tubes (Salmon et al., 1969) , cellulose carbonate 
(McLaughlin et al., 1971) and filter paper discs (Ceska and 
Lundkvist, 1972). In the 'sandwich' method, anti-IgE or 
allergen is coupled to the solid phase, e.g. a paper disc, and
the sample containing IgE is presented to it. IgE present 
in the sample binds to the anti-IgE on the disc. Highly- 
purified anti-IgE is radiolabelled and when added, forms a 
third layer in the system. The gamma count then varies 
directly with the concentration of IgE present in the sample 
or standard. This test is used in this laboratory for the 
measurement of IgE in experimental animals, and will be 
described in detail later.
Diffusion in gel reactions have been used since 1905, 
and are relatively simple to perform. Their use in modem 
immunochemistry began with the work of Oudin, who introduced 
the technique of antigen diffusing into agar which contained 
antibodies (Oudin, 1946) . This single linear diffusion was 
extended by Mancini, Carbonara and Keremans (1965) to single 
radial diffusion. They incorporated antiserum into the agar 
layer and cut wells into which the antigen was placed, 
subsequently diffusing radially into the agar to form a ring 
of precipitate at the point of equivalence. A relationship 
is described between the diameter of the precipitin ring and 
the concentration of antigen in the well. A calibration 
curve may be constructed using standard concentrations of 
antigen so that unknown concentrations in the samples can be 
read off.
Rowe (1969) described a modified version of Mancini's 
single diffusion which increased the sensitivity of the test
and so the lower levels of IgE in normal serum could be 
detected. This technique was subsequently used to assay 
IgE in the rat (Jarrett and Bazin, 1974). Briefly, the 
procedure is as follows; goat anti-rat IgE is incorporated 
into agar using dilutions of 1:2000, the mixture is poured 
on to a glass plate. Wells are punched in the agar and 
dilutions of serum samples and test samples are dispensed 
into the holes. The plate is incubated at 37°C for 48 hours, 
after which it is washed in buffer. It is subsequently 
incubated with radiolabelled rabbit anti-goat IgG and after 
further washings is dried and placed in contact with a 
photographic film for 2-3 days. When developed, the 
precipitin rings are visible on the film. The radiolabelled 
stage is essential as the precipitin rings are otherwise 
invisible due to the small quantity of IgE in normal serum. 
The ring diameters are proportional to the concentration of 
IgE in the samples.
With the development of the rat PRIST, the Rowe-Mancini 
method has largely been superseded, but it may still be use­
ful in laboratories where a gamma counter or the purified 
reagents necessary for the PRIST are unavailable.
A number of other radioimmunoassays for the measurement 
of serum IgE have been developed. A sensitive double anti­
body radioimmunoassay has been described by Gleich, Averbeck
and Swedlund (1971), who studied sera from normal
individuals and those with hay fever and asthma. The
technique used was similar to that employed by Morgan
and Lazerow (1963). Rabbit anti-IgE (0.1 ml) and an
131aliquot of radiolabelled I IgE (0.1 ml containing 
approximately 0.1 ng of protein) is added to standard 
or test samples (0.1 ml) in tubes. The system is 
incubated for 24-96 hours at 4°C, after which goat anti­
rabbit IgG (0.2 ml) is added, and lastly some normal 
rabbit serum. Following a further incubation period, 
the tubes are spun at 3,500 revs for 30 minutes, the 
supernatant decanted and the precipitate counted. Counts 
in tubes containing IgE standard or test samples are 
divided by the total radioactive count and are expressed as a 
percentage. Standard samples are run and a curve constructed 
to include a range of 1 ng - 14 ng of IgE. The percentage 
of Igfi in the sample is read off and the concentration of 
IgE obtained.
A comparison of three radioimmunoassays for the 
measurement of total serum IgE was conducted by Polmar, 
Waldman and Terry (1973) ; the double antibody technique 
(Gleich et al., 1971), sepharose-bound antibody (Johansson 
et al'. , 1968) and bromoacetylcellulose (BAC) -bound antibody 
(Mann et al., 1969). They detected IgE in patients with 
schistosomiasis having very high levels, as well as cases
of ataxia telangiectasia - an immunodeficient condition 
in which IgE levels are very low. All three assays gave 
similar readings in the high cases, but distinctive 
differences were apparent with the lower levels. The 
double antibody technique confirmed its sensitivity rating 
and gave the low readings expected for immunodeficient 
sera, the BAC and, to a lesser extent, the sepharose 
technique, gave levels which would otherwise be considered 
normal rather than actually immunodeficient.
b) Detection and measurement of allergen specific IgE
using anti-IgE
A sandwich technique similar to the RIST, the radio- 
allergosorbent test (RAST), is used as an in vitro radioimmuno­
assay, for the detection and measurement of allergen specific 
IgE. This test, introduced by Wide and colleagues (Wide 
et al. , 1967) , has been used in the diagnosis of allergies, 
for which purpose a commercial kit has been recently developed 
by Pharmacia. The RAST is based on the anti-globulin principle 
of Coombs and colleagues (1953). Relevant antigen is coupled 
to paper discs (Ceska and Lundkvist, 1972) which are then 
incubated with test serum. Excess serum is washed away and 
the discs are further incubated with radiolabelled anti-IgE.
The counts on each disc are then directly proportional to the 
IgE antibody content present in the test serum. A variety of 
allergen extracts are available commercially, e.g. ragweed and
timothy grass, and may be coupled to the paper discs. 
However, the potency or allergenic activity of such 
extracts may vary between different companies, and 
until standards are available, results from different 
laboratories cannot be compared.
The Red Cell Linked Antigen-Antiglobulin Technique 
(RCLAAR), an immunoglobulin specific technique based 
on agglutination, was introducted by Coombs et al. ,
(1953). Allergen is coupled by photo-oxidation to 
rabbit antihuraan red cell antibodies. Such rabbit 
antibodies will no longer agglutinate human red cells, 
but instead when mixed with red cells will combine with 
them and link the coupled antigen to the cells. On 
incubation with test sera any allergen specific IgE 
will be adsorbed on to the cell surface. Specific 
antiserum to IgE is then added to cause agglutination 
of the sensitised cell suspension; this is subsequently 
read by the pattern of sedimentation of the cells.
Good correlation has been found between the Red Cell 
Linked Antigen-Antiglobulin Reaction measuring reagin 
and the results of provocation testing in atopic patients 
(Coombs et al., 1968).
Some of the techniques described have been in 
common use in other laboratories, but others, particularly 
the RIST as applied to rat IgE detection, have been 
developed here with the collaboration of Dr. H. Bennich 
and his colleague Dr. T. Karlsson of Aarhus University, 
Denmark and Uppsala University, Sweden, and Dr. H. Bazin 
of the University of Louvain, Brussels. There follows 
in this section a detailed description of this technique 
which is extensively used in this laboratory.
DETECTION OF IgE IN THE RAT
The use of the rat as a model for IgE studies gained 
greatly in potential as a result of the discovery of immuno- 
cytomas occurring in, and peculiar to, the Lou/Wistar strain 
of rat (Bazin et al., 1973). These tumours originate in the 
ileocaecal lymph node and are transplantable in histocompatible 
animals, retaining their capacity for immunoglobulin secretion 
during successive transplantations. The monoclonal immuno­
globulins synthesised by these tumours have been purified and 
used as antigens for the production of antisera. In the test 
described here, specific antiserum to the IgE myelomas IR2 or 
IR162 is used in the detection of total circulating IgE by the 
'sandwich' radioimmunoassay designed by Ceska and Lundkvist (1972) .
Detection of allergen specific IgE by Passive Cutaneous 
Anaphylaxis is also described.
1. Detection and Measurement cf Total IgE in the Rat 
by the Radioimmunosorbent Technique (RIST)_______
The Principle of the test
The test involves a three-layered system with a solid phase 
immunosorbent taking the form of anti-IgE antibodies coupled to 
paper discs. These are dispensed into small plastic tubes and 
incubated with standard or serum samples containing IgE. Any 
IgE present binds to the anti-IgE on the disc; unbound protein 
is washed away. A second incubation presents radiolabelled anti- 
IgE antibodies to the system which then binds to the anti-IgE-IgE 
complex, forming the third layer of the 'sandwich'. Unbound 
protein is washed out and each tube is counted on the gamma counter.
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The numbers of counts varies directly with the IgE
present in the sample.
Paper disc
anti-IgE IgE in the sample
Anti-IgE-IgE
complex
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MATERIALS AND METHODS
G
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Paper discs
Filter paper discs with a low ash content were used.
We have used Whatman No. 1 with success. Discs 6 mm in 
diameter were initially punched with an office paper punching 
machine, but subsequently were purchased as a special order 
from Whatman Ltd. 5 gms were soaked in distilled water with 
several changes to remove suspended particles.
Activation of discs
This process was carried out in a fume cupboard.
The discs were activated using Cyanogen bromide 
according to the method of Ceska and Lundkvist (1972) with 
some'modifications. Cyanogen bromide crystals were weighed 
out in a stoppered container and added to 100 ml of distilled 
water to form a 3-5% solution. The crystals were completely
dissolved using a magnetic stirrer. The discs were then 
empti.ed into the cyanogen bromide mixture and 1M NaOH 
solution added dropwise to maintain the pH between 10-11 
until about 20 ml of the base had been consumed. The 
solution was aspirated and the discs washed several times 
in ice-cold 0.005 M NaHCO^ buffer to a total of 5 litres, 
followed by similar washings in 2 litres of ice-cold 
distilled water.
The discs could then be coupled immediately or could 
be dried by successive washings in 25%, 50%, 75% and 100% 
acetone and stored in an air-tight container at 4°C for 
several months.
Antiserum
The antiserum was raised in rabbits by immunising them 
with 0.5 mg of purified myeloma IR162, injected intra­
muscularly in Freund's complete adjuvant. A booster dose 
of 0.5 mg was given two weeks later in Freund's incomplete 
adjuvant, and the rabbits bled two weeks after this. Goats 
were also used for this purpose.
The rabbit anti-rat IgE thus obtained was rendered 
epsilon (E) chain specific by absorption with gluteraldehyde 
cross linked (Avrameas and Temynck 1969), normal Sprague Dawley 
rat serum, which has a very low content of IgE. The anti­
bodies were then purified by adsorption to an immunosorbent
column of purified myeloma IR2 coupled to Sepharose 4B, 
with subsequent elution. IgE of a different myeloma was 
used (IR2) to cause elimination of IR162 idiotype specific 
antibodies.
Coupling procedure
As the first layer of the 'sandwich1, either purified 
antibodies or a gammaglobulin fraction of an anti-IgE serum 
was coupled to the discs. Where the latter was used, it
was assumed that 1% of the protein was specific for IgE. 
100-200 ng of pure anti-IgE antibodies or anti-IgE globulin 
containing the equivalent amount of antibodies, were 
incubated with activated discs (about 200/universal in 20 ml 
0.1 M NaHCO^ pH9) for 4 hours at 4°C on a vertical rotator. 
After use, the coupling solution could be frozen and re-used 
several times by adding 20-30 ng of fresh IgE antibodies. 
After incubation, the solution was decanted and kept, and 
unbound protein was washed away from the discs by three 
washes in 0.5 M NaHCO^ pH9. Remaining active sites on the 
discs were blocked by incubation with 0.1 M TRIS buffer pH8, 
overnight in the refrigerator or 3 x 1 hour washes at room 
temperature. After this the discs were washed 3 times 
alternately in 0.5 M NaHCO^ buffer and acetate buffer pH4, 
each wash lasting for 30 minutes to ensure that any non- 
specifically bound protein was washed away. Finally, 
following three washes in incubation buffer, the discs were
ready for use. They could also be stored in incubation 
buffer at 4°C for up to 3 months. Before use, they were 
washed twice in incubation buffer to remove any anti-IgE 
which had become unbound.
Incubation buffer
This consisted of 0.05 M phosphate buffer pH8 made 
up as follows: 7.3 gm NaCt, 0.75 gmB.S. A . aid 2 . 3 ml Tween 
in 2.5 litres. A stock 0.5 M PO^ buffer was usually made 
up and diluted 1:10 when required. This could be stored 
at 4°C with the addition of a few drops of Sodium azide 
(10%) .
Standard IgE
Standards of purified myeloma IR162 or IR2 were 
prepared by Dr. H. Bennich. The standards were diluted 
in incubation buffer to concentrations ranging from
1 ng - 20 ng/50 (il, were stored at -20°C and used 
repeatedly.
Labelling of anti-IgE antibodies
The procedure followed was the chloramine T method 
of Greenwood, Hunter and Glover (1963).
25 jil of 0.5 M PO^ buffer pH7.5 was added to 1 mCi of
125I,in a bijou bottle. 25 p.g of purified anti-IgE in 
0.5 M PO^ buffer was added to the above, followed by 25 |il 
of a 1 mg/ml solution of chloramine T. The latter acts as
an oxidising agent and starts the binding of I to
the protein. The mixture was rotated continuously for
30-90 seconds. At the end of this time 25 pi of a
2 mg/ml solution of Sodium metabisulphite was added to
stop the binding reaction.
Some crystals of Potassium iodide were added to
make the mixture 'heavy', i.e. excess iodine to
facilitate better separation. The labelled protein
was then placed on a G200 column (50 x 1 cm) equilibrated
with 0.05 M PO. + 3% BSA. The eluate was collected in 4
0.5 ml fractions. Two peaks were observed when the tubes
were counted on the gamma counter, the first was labelled
125
protein and the second was unbound I (see Fig. 2) .
The few fractions forming the tip of the first peak
were taken and pooled for use in the test. Fractions
from the leading and declining portions of the first peak
were discarded, as the former contain aggregates and the
125
latter breakdown products and some free I. An aliquot 
(100 pi) of the pool was counted at 1:100 dilution for 
1 minute to estimate the total count. The pooled eluate 
was then stored at -20°C and kept for not longer than 
4-5 weeks. Subsequently, before each test, radioactivity 
per 100 pi aliquot was adjusted to 20,000-30,000 counts 
per minute using incubation buffer as diluent.
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Fig. 2 Separation °f^ 2 5  I“labelled anti-IgE antibodies 
from unbound I. Fractions collected from a 
G200 column eluate. Six fractions from the top 
of the first peak representing labelled protein 
were pooled and used in the RIST.
Test procedure
Each antibody coated disc was dispensed into a 
Luckham plastic disposable tube (LP3) using a pasteur 
pipette attached to a vacuum pump. The tubes were 
numbered and arranged in racks.
Automatic pipettes and disposable plastic tips 
were used throughout the test procedure. 50 j j l I  of 
incubation buffer was pipetted into each tube. 50 pi 
of the standard at the known concentrations and the same 
of samples were added. Samples were diluted according 
to the expected values of IgE present; high IgE sera,
i.e. from parasite-infected animals, were diluted at 
1:1000 or 1:2000, those with expected low levels were 
diluted 1:10. At these dilutions the IgE content usually 
fell within the range of the standard curve.
Each assay was done in duplicate and a buffer control
without standard or sample was included at the beginning.
The tubes were incubated for 3-4 hours at room temperature
with agitation, at the end of which unbound protein was
washed away with 3 washes in incubation buffer. 100 pi of 
125I-anti-IgE was dispensed into each tube. An additional 
tube was added to measure the total count of the radioactive 
aliquot, previously set to approximately 20,000 counts per 
minute. Following overnight incubation, the tubes were 
washed four times in incubation buffer and then counted on 
the gamma counter for a minute.
Results and Discussion
The results of a rat RIST are shown in Table 1 
and Figure 3.
The mean was calculated for each set of tubes and 
from the standards a curve was then constructed on 
lin-log graph paper (3 cycles log x h mm 1 cm). The 
sample counts could then be read off and their total 
IgE content computed by multiplying by 20 and by the 
dilution factor.
This direct radioimmunoassay is sensitive and 
easy to perform, the best results being obtained when 
unknown sample counts fall on the straight portion 
of the standard curve (Fig. 3). Levels as low as 
5o ng/ml could be detected and sample with very high 
ccncentrations were diluted appropriately until they 
fell within the straight portion of the standard 
curve. A normal rat serum sample was run in every 
test to check reproducibility.
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TABLE 1. Results of a rat RIST performed on sera from 
an immunosuppression experiment.
Tube Mean Counts IgE
No. Contents Dilution per minute concentration
1 Buffer control - 327 -
3 Standard IgE - 363 0.05 ng/50 ji£
5 It - 401 0.1
7 IV - 453 0.2
9 II - 687 0.5
11 II - 947 1.0
13 11 - 1523 2.0
15 II - 4475 5.0
17 If - 6940 10.0
19 11 - 8966 20.0
21 II - lOOOO 50.0
23 Normal rat serum 1:10 5218 1.30 jig/ml
25 Eefore immunisation 1. IV 2664 0.66
27 II 2. II 818 0.15
29 II 3. II 743 0.12
31 II 4. 11 686 0.11
33 II 5. II 1140 0.27
35 IV 6. II 1276 0.31
37 II 7. II 942 0.20
39 D.14 after 1 . II 1377 0.35
41 immunisation 2. II 1163 0.28
43 II 3. 1:50 682 0.23
45 II 4. 1:10 883 0.18
47 11 5. II 1250 0.30
49 II 6. If 1277 0.31
51 Controls 1 . VI 1065 0.24
53 II 2. II 3661 0.84
55 II 3. II 5568 1.40
57 II 4. II 3900 0.90
59 II 5. II 6993 2.04
Cont’d.
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TABLE 1 (Cont'd.)
Tube Mean Counts IgE
No. Contents Dilution per minute concentration
61 D.12 after infection 1 . 1:100 9539 59 .00 |ig/ml
63 fl 2. II 8214 30.40
65 II 3. If 9371 52.00
67 It 4. II 8887 39.00
69 IV 5. II 7636 25.50
71 Controls 1 . 1:1000 7696 260.00
73 II 2. II 8103 296.00
75 II 3. II 7103 215.00
77 It 4. II 7113 217.00
79 II 5. If 9064 425.00
81 Total count ±_ _ 20770 _
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Fig. 3 A typical standard curve obtained by plotting 
radioactive counts against the concentration 
of IgE in standards. See p.40
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2. Detection and Measurement of Specific Antibodies
in the Rat by PCA_______________________________
The method most commonly used for assessment of specific 
IgE in the rat is Passive Cutaneous Anaphylaxis (PCA). This 
in vivo assay was developed by Ovary (1952) and illustrates 
the observations originally made by Prausnitz and Kustner (1921) 
that skin sensitising ability of reagins could be transferred 
to normal individuals. The receptors on mast cells/basophils 
are specific for IgE of the homologous species and so PCA 
reactions for the detection of IgE antibodies must be performed 
on the same species or occasionally closely related species, 
e.g. human reagins can be detected by PCA on primates and mouse 
IgE by PCA in the rat.
The injected IgE antibody in the test serum sensitises the 
tissues by attaching to the mast cells in the skin. It remains 
for a considerable period of time - at least 3 weeks (Brocklehurst, 
1973). On intravenous challenge with the appropriate antigen 
and a dye (such as Evan's blue which attaches to the plasma 
albumin), the antigen attaches to the cell bound antibody and 
this union triggers off a series of biochemical events, culminating 
in the release of vasoactive compounds from the mast cell. These 
substances cause an increase in vascular permeability which results 
in leakage of the dye at the site of the injection. Elsewhere the 
dye is retained in the blood. The titre of the serum under test 
is taken as the reciprocal of the last dilution giving a reaction 
of 5 mm in diameter.
The PCA is not inhibited by antigen excess, 
therefore it is advisable to use large excesses of 
antigen, otherwise the resultant PCA titre might 
not truly be a function of the amount of antibody 
present (Ovary, 1964).
The number of mast cell receptors available for 
passive sensitisation will depend not only on the 
number of mast cells actually present, but also on 
the total serum IgE level of the recipient animal.
It has been shown that helminth infected rats become 
almost completely refractory to passive sensitisation 
for the production of PCA or systemic anaphylaxis 
(Jarrett et al., 1971). A comparable effect has been 
reported in human patients with IgE myelomas (Ogawa 
et al., 1971) and subsequently in parasite infected 
human patients (Bazaral et al., 1973). The mechanism 
of this phenomenon is that in animals producing very 
high levels of serum IgE, the mast cell receptors for 
this immunoglobulin become saturated and hence unavailable 
for passive sensitisation.
Care should be taken when administering PCA 
injections to ensure that the serum is not injected 
subcutaneously, as this gives diffuse reactions if any. 
Proper intradermal injections result in superficial blebs 
which remain visible for at least 30 minutes.
IgG2a antibodies also elicit PCA reactions, but 
do not remain fixed to the skin sites for long periods.
A 4 hour PCA reaction for the detection of these anti­
bodies is as follows: an aliquot of test serum is heat
inactivated at 56°C for 1-3 hours; this inactivates IgE 
but not IgG2a. Four normal rats are used and each of 
the recipients are given two sets of injections intra- 
dermally; one of heat inactivated serum and one of 
normal serum. One pair of rats receive the intravenous 
challenge 4 hours later for detection of IgG2a anti­
bodies, the other pair 48 hours later to check for the 
complete inactivation of IgE antibodies. Four hour PCA 
reactions with adequately heat inactivated serum are 
mediated by IgG2a antibodies. If the 48 hour PCA is 
still positive with the heat inactivated serum, it means 
that IgE antibodies have been incompletely inactivated 
and therefore require further inactivation followed by a 
retest.
Method
Sera were diluted in saline by serial, doubling 
dilutions. 0.1 ml aliquots were injected intradermally 
with 26 gauge x 3/8" needles, and 1 ml plastic disposable 
syringes. Each sample was done in duplicate or triplicate 
in different rats to control for individual variation.
The recipients were anaesthetised with trichloroethylene 
and their backs shaved with small animal clippers.
Usually ten intradermal injections could be done on one 
rat, three down either side and four down the mid-line.
The rats were then left for a period of 24-72 hours to 
allow for fixation of IgE to the tissues and for the 
diffusion away of any IgG reaginic antibody.
Following this, the rats were challenged with antigen 
(e.g. 2.5 mg egg-albumin or 0.5 ml whole worm extract), 
together with 0.5 ml Evan's blue dye; both administered 
intravenously using a 25 gauge 1" needle attached to a 
1 ml syringe. Intravenous challenge was by injection 
into the tail vein which had been dilated by brief 
immersion of the tail into warm water. The reactions 
were read after 20 minutes and scored as positive or 
negative. It was sometimes necessary to study the 
reactions on the inside surface of the skin where their 
borders were often more clearly delineated.
Some sera with particularly high titres of IgE, 
e.g. parasite potentiated responses, if done at too low 
a dilution gave very large reactions which could cover 
a whole back and mask the results of other injections.
To avoid this, it was important to dilute high titre 
sera appropriately, e.g. starting at a dilution of 1/256. 
Sera with unknown content of IgE antibody were usually 
started at a lower dilution.
At the intravenous challenge, the rats must 
not come in contact with the trichloroethylene in 
the anaesthetic jar, as this is an irritant to the 
skin causing non-specific release of the vasoactive 
compounds.
SECTION II
IgE PRODUCTION IN THE RAT
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GENERAL INTRODUCTION
Mota (1964) found that two distinct antibodies were evoked 
in the rat following immunisation with antigen and adjuvant. In 
addition to the usual precipitating antibody a small quantity of 
'mast cell sensitising' antibody was detected in the early post­
immunisation period. This antibody sensitised the animal for 
cutaneous and systemic anaphylaxis. It was found to sensitise 
mast cells in vivo and in_ vitro causing damage to the cells on 
further encounter with specific antigen and was therefore called 
'mast cell sensitising' antibody.
Properties
Rat 'mast cell sensitising' antibody was discovered to be 
quite independent of the precipitating antibody. It was found 
to be thermolabile being inactivated at 56°C. On zone electro-- 
phoresis the anaphylactic antibody migrated as a y8-globulin 
ahead of the main ^  antibody -f ultracentrifugation demonstrated 
a sedimentation coefficient intermediate between 7s and 9sj 
immunoelectrophoresis however did not reveal any precipitin line 
that could be ascribed to anaphylactic antibody (Binaghi et al., 
1964). Quantitation was by PCA and the characteristics observed 
exhibited a similarity to human reagins as measured by the P-K 
test, i.e. long incubation required for maximal sensitisation 
and persistence of antibody at the skin site for many days 
(Binaghi and Benaceraff, 1964).
An antiserum was prepared to rat homocytotropic antibody 
which failed to recognise rat IgGa, IgGb, IgA, IgM or but 
precipitated only with an electrophoretically fast immuno­
globulin with antigen binding capacity. This antiserum used 
as an immunosorbent could remove the PCA activity attributed 
to rat homocytotropic antibody from rat antiserum. This unique 
class of rat homocytotropic antibody was designated rat IgE 
(Stechschulte et al., 1970).
The rat has latterly been used by several workers as a 
model for the study of production of IgE despite some obvious 
disadvantages, namely the apparent requirement for large doses 
of antigen, the transient and quantitatively poor nature of 
the IgE response and the inability to evoke significant booster 
responses. These features originally described by Mota (1964) 
and Binaghi and Benaceraff (1964) were the general experience 
of subsequent workers.
Regulation and Production of IgE in the Rat
Tada and Okumura (1971) have studied the control of IgE 
production in Wistar rats, using as standard immunisation 
technique, a footpad injection of Ascaris suum - DNP and an 
intraperitoneal injection of Bordetella pertussis (killed) 
organisiiB as adjuvant, followed 5 days later by a booster of 
antigen alone. Specific IgE antibody to the hapten was found 
to disappear rapidly (35-40 days) and could not be boosted by 
a subsequent dose of antigen. A series of experiments were
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conducted by Tada and colleagues, in which enhancement 
or inhibition of reagin formation in the rats was effected 
by various immunologic manipulations. It was found that 
passively administered antigen specific IgG antibody suppressed 
the IgE response (Tada and Okumura, 1971) as had also been 
found in rabbits (Strannegard and Belin, 1970) and mice 
(Ishizaka and Okudaira, 1972). It was suggested that a 
similar mechanism could operate naturally. Enhancement of 
IgE antibody production was reported to occur after splenectomy 
and/or thymectomy (in adults) after a lethal dose of 
X-irradiation, and following administration of a variety of 
immunosuppressive drugs such as cyclophosphamide, cortisone 
or actinomycin D, or a small dose of anti-lymphocyte serum 
(reviewed by Tada 1975). The broad interpretation of these 
enhancing effects was that as a result of these various 
treatments there occurred a selective depletion of certain 
populations of lymphoid cells, probably of thymic origin, 
which regulated reagin production. Confirmation of this 
was obtained when T cells primed with carrier, passively 
transferred to hapten-carrier primed recipients, were observed 
to terminate the IgE response (Tada and Okumura, 1971). 
Similarly, it was found that cell free extracts from thymo­
cytes and spleen cells primed with hapten-carrier, or just 
carrier, showed suppressive activity (Okumura and Tada, 1974).
Later a helper cell was also described when the same 
crude extract from thymocytes restored ability to produce
reagin in neonatally thymeatomised rats (Okumura and 
Tada, 1974) and it was suggested that the inductive and 
suppressive effect was associated with the same molecule.
However, further studies showed that they were different 
molecules and that the helper component had a molecular 
weight comparable to 7s IgG and contained Fab and p 
determinants. Unlike the suppressor activity it could 
not be absorbed by ALS (anti-lymphocyte serum) and its 
properties were similar to IgT, the monomeric form of 
IgM from T cells in mice.
The conclusion drawn from these observations was that 
the control of reagin production was exerted by a 
combination of the effects of the two populations of 
antigen specific T cells as well as (possibly only under 
some conditions) the antibody mediated "feedback" mechanism.
Other investigations in IgE production suggested there 
were strain differences in ability to mount a good IgE 
response. For example, when subjected to similar immunisation 
procedures SJL inbred mice and ACI and Wistar rats were poor 
responders, whereas SW55 inbred mice and Brown Norway and 
Hooded Lister rats were good responders (Levine and Vaz, 1970; 
Murphey et al., 1974; Jarrett and Stewart, 1974) .
The recent discovery of non-antigen specific T suppressor 
lymphocytes has been reported. Watanabe et al.,(1976) and Chiorazzi 
et al.,(1977) using different immunisation schedules employing 
DNP conjugates in SJL mice, demonstrated that there normally
exists in this strain a non-antigen specific suppressor 
cell which selectively suppresses both primary and secondary 
IgE responses. The subjection of poor IgE responders to 
X-irradiation, appropriate doses of cyclophosphamide or 
anti-lymphocyte serum enhanced IgE production. The mice 
can be restored to their former state by the transfer of 
syngeneic cells from unimmunised donor animals and this 
restoration is inhibited by pre-transfer treatment of spleen 
cells with anti-0 serum and complement. This showed that 
the cells involved were T cells (Chiorazzi et al., 1977) .
These suppressor T cells appear to act selectively on IgE 
antibody response with no effect on IgG.
These findings have shed a new light on the strain 
differences mentioned above. Poor IgE responsiveness is 
now seen as a genetic capability, inherited as an active 
inhibition of IgE responses, rather than a genetic inability 
to form IgE antibodies. Also supporting this theory, is 
the identification of the level of action of these suppressor 
cells. By different combinations of immunisation and 
irradiation times, the site of action was indicated to be 
at the helper T cell induction, as this suppression was 
alleviated by exposure to X-irradiation at the time of initial 
carrier priming rather than at any other point (Chiorazzi 
et al., 1977).
Production of IgE responses in the rat basically 
depends on the dosage, the manipulation of which reveals 
the strains capacity to respond. Animals of poor 
responder strains require a large dose of antigen, 
probably to "overcome" the non-specific suppressor 
mechanisms, but at the same time the large dose activates 
specific suppressor mechanisms which abrogates the response 
and inhibits booster responses. By initially immunising 
with small doses (1 Jig) of antigen, Jarrett and Stewart 
(1974) obtained a good primary IgE response in Hooded Lister 
rats, which could be boosted. A large primary dose, however, 
inhibited the formation of a secondary response.
Hooded Lister rats are good IgE responders and have 
been used for a long time in this laboratory for the study 
of IgE production. By contrast to poor IgE responders it 
would seem that these animals are deficient in their non­
antigen specific suppression or at least defective in its 
expression, since IgE responses can be formed in them on 
exposure to minute doses of antigen. The administration of 
large doses of antigen, on the other hand, activates other 
(antigen specific) regulatory mechanisms which eventually 
terminate the response and booster responses.
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1. REAGINIC ANTIBODY RESPONSES TO INTRADERMAL AND ORAL 
ADMINISTRATION OF EGG-ALBUMIN IN THE RAT
Introduction
The optimal conditions for the induction of reaginic 
antibodies have yet to be defined with the objective of gaining 
a better understanding of the development of IgE-mediated 
allergic diseases.
It had previously been found (Jarrett and Stewart, 1974) 
that reagin responses were evoked in Hooded Lister rats by 
intraperitoneal immunisation with any one of a range of doses 
from 1 mg - 1 jig egg-albumin. Booster responses could be 
evoked but only in animals initially immunised with the smaller 
doses of antigen. Large immunising doses of antigen, i.e. 
excess of 100 fig had an inhibitory effect on the development 
of challenge responses.
Access by antigen to the peritoneal cavity, however, is 
not a method whereby sensitisation is likely to occur naturally. 
Here experiments are described in which egg-albumin was 
administered orally or by intradermal injection in order to 
discover whether IgE production could be induced by these means, 
whether dose effects similar to those obtained by intraperitoneal 
inoculation could be observed, and whether immunisation by these 
routes would have any special effects on the IgE response.
In preliminary experiments a booster response was 
evoked in rats which were immunised with egg-albumin 
in traperi tone ally and challenged with 10 ng .intradermally 
(Jarrett and Stewart, unpublished). McDougall (1974) 
found that both primary and secondary IgE responses could 
be evoked by the ingestion of egg-albumin dissolved in 
the drinking water. The rats were given water, in which 
egg-albumin was dissolved at a concentration of 100 )ig/ml, 
ad libitum for periods between 24-48 hours during which 
time it wras estimated that the quantity consumed by each 
rat was between 2 mg - 5 mg of egg-albumin. This however 
was probably an overestimate as allowances were not made 
for spillage and denaturation of the protein.
The experiments described below were designed to find 
the minimum dose of antigen necessary to evoke primary and 
secondary IgE responses by the intradermal and oral routes.
Materials and Methods 
Animals
The animals used were Outbred female Hooded Lister 
rats weighing 150-200 g obtained from Animal Suppliers 
(London) Ltd. They were fed a diet free of egg proteins.
Antigen administration
Sigma egg albumin (EA) Grade V, freshly prepared to 
a concentration 10 ,mg/ml in saline was diluted so that the
appropriate dose was contained in 0.5 ml. Intradermal 
injections were performed on the shaven back with a 26- 
gauge needle so that a superficial pale bleb appeared 
at each injection site. 0.1 ml of fluid was injected 
into each of five sites. For oral sensitisation the 
dose was administered by stomach tube, the latter 
consisting of a 3 cm length of nylon intravenous cannula, 
diameter 1.65 mm, (Portex Ltd., Hythe, Kent) attached 
to a 1 ml syringe. On some occasions (as indicated in 
the Results section) the animals were deprived of food 
but not water for 24 hours preceding intubation.
Bordetella pertussis
A suspension (Wellcome Biological Reagents) containing 
1010 organisms was injected intraperitoneally at the same 
time as the administration of the immunising dose. 
Subsequent doses of antigen were given without adjuvant.
Statistical analysis
Results were compared where appropriate by Student's 
t-test using logarithmically transformed antibody titres. 
Animals that did not produce detectable antibody were not 
included in the calculations. The number of non-reacting 
animals in each group is shown in the Results section.
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Results
Reaginic anti-body response after intradermal injection 
of antigen
Table 2 shows the individual reaginic antibody titres 
of three groups of animals immunised with 1 mg, 100 jig 
and 10 jig EA respectively, and then challenged after 30 
days with 0.1 fig EA. Both doses were given intradermally 
and B. pertussis was administered with the first dose but 
not with the second. Clearly, even the smallest 
sensitising dose of 10 [ig administered by this route was 
sufficient to induce an IgE antibody response. Moreover,
0.1 jig EA induced secondary responses which were significantly 
greater than the primary response in Group 2 (p <0.05) and 
Group 3 (p <0.01) although not in Group 1.
In order to test the efficacy of even smaller doses 
of EA for both primary and secondary IgE responses, the 
experiment set out below was performed.
Group No. of rats Amount of EA injected intradermally
First dose Second dose Third dose
(Day 0) (Day 31) (Day 60)
1 16 10 fig la 10 ng 1 ng
lb 1 ng 1 ng
2 15 1 fig 2a 10 ng 1 ng
' 2b 1 ng 1 ng
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TABLE 2. Reaginic antibody response after intradermal
injection of egg-albumin (EA) sensitising doses 
ranging from 1 mg to 10 jig, challenge dose 0.1 j_ig.
Rat
No.
Group 
1st dose 
1 mg
1
2nd dose 
0.1 jig
- Group 
1st dose 
lOO (ig
2
2nd dose 
0.1 [ig
Group 
1st dose 
10 jig
3
2nd dose 
0.1 jig
1 0 8 256 512 64 64
2 128 512 64 128 64 2048
3 256 128 32 128 32 512
4 32 256 32 128 16 128
5 8 64 0 0 256 2048
6 128 512 128 512 4 512
EA PCA titres 13 days after 1st dose and 4 days after 2nd dose 
of EA.
The results are shown in Table 3.
The most important feature of the primary IgE response 
was that it was detectable in twelve of the sixteen animals 
in Group 1 immunised with 10 jig but in only five of fifteen 
animals of Group 2 immunised with 1 jig. Second doses of 
10 ng or of 1 ng, however, evoked secondary responses not 
only in the rats which had previously produced reagins, 
but also in the majority of those which had not. By 26 
days after challenge the IgE levels had declined again 
or had disappeared so that the overall picture in each 
group resembled that of the primary response. At this 
point the animals of all groups were challenged again 
with 1 ng EA given intradermally, and were exsanguinated 
4 days later. The figures in Table 3 show that the IgE 
antibody titres were re-elevated in some rats of each 
group but this was most striking in Groups lb and 2b 
which had been challenged with 1 ng on both occasions.
It is only in the latter two groups that the mean titres 
for day 26 after the second dose and day 4 after the 
third dose are significantly different (p <0.025 for both).
Reaginic antibody response after orally administered 
antigen
In order to discover the most effective and the lowest 
effective dose for the stimulation of IgE antibody production 
following immunisation by the oral route, five groups of
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TABLE 3. Reaginic antibody response after intradermal 
injection of EA sensitising doses of 10 or 
1 jig, challenge doses of 10 or 1 ng.
Treatment of rats EA PCA titres of 8 rats
Group Ag doses 
injected
Days bled 
after each dose 1 2 3 4 5 6 7 8
la 1st 10 jig 12 8 128 8 0 4 32 8 0
2nd 10 ng 4 512 2048 64 4 256 512 512 128
26 32 64 0 0 32 32 8 2
3rd 1 ng 4 512 128 0 1 64 16 8 64
lb 1st 10 jig 12 8 1 32 128 0 8 0 16
2nd 1 ng 4 512 16 512 512 8 512 64 128
26 32 1 128 128 2 128 2 16
3rd 1 ng 4 512 8 512 256 8 256 512 256
2a 1st 1 jig 12 C 8 O 0 4 0 4
2nd 10 ng 4 0 512 128 2 512 64 1024
26 0 16 8 0 16 2 8
3rd 1 ng 4 0 Died 256 2 4 128 64
2b 1st 1 Jig 12 8 0 0 1 0 0 0 0
2nd 1 ng 4 512 32 128 128 0 8 0 4
26 2 0 0 2 0 0 0 4
3rd 1 ng 4 1024 2 512 256 8 64 0 64
*Antigen injected on days 0, 31 and 60.
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eight rats were given doses of EA increasing by ten-fold 
increments from 10 jig to lOO mg inclusive, by stomach tube.
B. pertussis was injected intraperitoneally. Food but not 
water had been withheld from the animals for 24 hours 
beforehand. The results in Table 4 show that each dose, 
even the smallest of 10 jig was effective in inducing an 
IgE response in some animals.
All the rats were challenged 31 days later with 100 jig 
EA given by stomach tube. No adjuvant was given and the 
rats were not fasted on this occasion . The inhibitory 
effect of the larger primary doses of antigen on secondary 
IgE responses which was demonstrated in our intraperitoneal 
immunisation experiments is again clearly evident (Table 4). 
Again, many rats which did not produce reagins after the 
first dose were found to have been primed, since a secondary 
response occurred after challenge.
The results of another similar experiment are shown in 
Table 5 in order to demonstrate that in some experiments 
using oral antigen we have been able to evoke a further 
booster response by giving a third dose of antigen after 
the decline of the secondary response, as in the experiments 
involving antigen given intradermally. In this experiment 
the rats were not fasted. The dose effects are again clearly 
evident.
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TABLE 4. Reaginic antibody response to orally administered
egg-albumin: sensitising doses ranging from 100 mg
to 10 |j.g, challenge dose 100 \ig
PCA titres 12 days after these doses of EA
Rat No Group 1 100 mg
Group 2 
10 mg
Group 3 
1 mg
Group 4 
100 fig
Group 5 
10 jig
1 8 0 0 8 0
2 0 1 4 1 0
3 32 8 8 0 0
4 O 0 0 1 8
5 0 8 16 0 8
6 0 4 2 0 1
7 2 8 0 0 0
8 16 128 128 0 0
PCA titre 4 days after challenge of all above rats V v i t h  100 \ig EA
1 0 0 0 128 128
2 O 0 8 128 64
3 128 32 512 64 512
4 0 O 2 64 1024
5 0 16 128 0 128
6 0 4 128 16 512
7 O 32 8 0 512
8 256 32 32 512 0
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In a final experiment, the results of which are shown 
in Table 6, ten rats in each of two groups were given 10 
pg and 1 jug EA respectively by stomach tube. Each group 
was then subdivided into two and the rats in each sub­
group were challenged with 10 pg or 1 jug respectively 27 
days later. An oral dose of 1 jug was found to be insufficient 
to sensitise rats for IgE production although it could evoke 
secondary responses in rats previously immunised with 10 jug 
EA.
Discussion
It has been demonstrated that intradermal or oral 
administration of small doses of antigen can elicit primary 
and secondary reaginic antibody responses in Hooded Lister 
rats. An EA dose as small as 1 jig injected intradermally 
or 10 jug given orally was found to be effective in 
stimulating a primary IgE response, if accompanied by an 
intraperitoneal injection of B. pertussis. In rats immunised 
with the above doses, secondary responses could be evoked by 
the administration of even smaller quantities of EA; thus,
1 ng intradermally or 1 |J.g orally, both without adjuvant.
The primary response was detected by day 10 after 
immunisation and the peak of the secondary response occurred 
on day 4 after challenge. The secondary response was manifest 
by the elevation of existing antibody levels or the rapid 
appearance (i.e. by day 4) of antibodies in previously negative 
animals. Intradermal injection was a more relieable immunisation
9
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Table 6. Reaginic antibody response after oral administration 
of EA sensitising dose 10 jig or 1 Jig*, challenge 
dose 10 jig or 1 jig.
PCA titre 12 days after 1st and 4 days after 2nd dose EA
Rat No. 1st response to 10 |ig
2nd response to 
10 jig 1 jig
1 0 0
2 0 0
3 0 128
4 8 128
5 2 128
6 0 16
7 0 32
8 0 0
9 O 2
io O 16
*Rats immunised with 1 jig EA orally did not produce detectable 
reagins either as a primary response or after challenge with 
the above doses.
procedure than oral administration. Only 50% of the 
orally administered antigen experiments have been 
successful. Unsuccessful experiments have been 
characterised by the failure of the. rats to produce IgE 
responses following immunisation with any of the doses 
used (100 mg - 10 |ig) . The reason for this failure is 
not known but it does not seem to depend on whether or 
not the rats are fasted beforehand. Other experimental 
conditions, to the best of our knowledge, have been kept 
constant.
As with intraperitoneal immunisations (Jarrett and 
Stewart, 1974) large doses of EA given intradermally or 
orally (>100 ]ig) had an inhibitory effect on the develop­
ment of secondary responses (Tables 4 & 5). It has been 
proposed that the absence of secondary responses may 
result from the stimulation of a population of suppressor 
T cells. Thus, a large amount of antigen presented on 
immunisation would activate antigen specific suppressor 
T cells whose effect would be to inhibit the proliferation 
of those precursor cells which would otherwise effect the 
next response.
However, by contrast with intraperitoneal immunisation 
tertiary responses were evoked after intradermal and oral 
presentation of antigen. This difference may not in fact 
be a function of the site of antigen presentation but of
the quantity of antigen that reaches the appropriate immuno­
competent cells. It is probable that intraperitoneal 
immunisation results in a relatively greater proportion of 
the administered dose being made available for stimulation 
and inhibition of IgE responses than when it is given by the 
other routes. Orally administered antigen in particular 
could be expected to be substantially degraded in the 
intestine. The occurrence of tertiary responses in these 
experiments raises the proposition that a challenge dose 
of even as little as 1 ng EA injected intraperitoneally (but 
not intradermally) is sufficiently large to be inhibitory to 
the development of the next IgE booster response. Our 
preliminary (unpublished)results support this proposition.
Numerous reports in the literature, and the success of 
local prophylactic immunisations, testify to the fact that 
antigenically intact protein molecules are rapidly absorbed 
across the intestinal epithelium and may stimulate local or 
humoral immune responses (Parkins, Dimitriadou and Booth, 
1960; Berenstein and Ovary, 1968; Korenblatt, Rothberg, 
Minden and Farr, 1968; Crabbe, Nash, Bazin, Eyssen and 
Heremans, 1969; and see review by Bienenstock, 1974). It 
has been proposed that one of the functions of secretory 
IgA is to limit such absorption by combination with antigen 
(Heremans, 1969), a concept which has been extended by the 
suggestion that the sensitisation of some atopic individuals
to common allergens is the result of a transient period of 
IgA deficiency or the idiosyncratic possession of low 
affinity IgA which, by default, allows the absorption via 
the mucosae of abnormally large quantities of antigen 
(Taylor, Norman, Orgel, Stokes, Turner and Soothill, 1973).
Paradoxically the results presented here for the rat 
show that the larger the dose of antigen absorbed by what­
ever route the less likely it is that persistent IgE 
responses will result.
The initiation and maintenance of IgE antibody responses 
in man may, as in the rat, depend on a critical combination 
of circumstances, prominently including the absorption by 
genetically predisposed individuals of minute quantities 
of antigen, initially in the presence of an adjuvant.
70
2. ADJUVANTS IN THE INDUCTION AND ENHANCEMENT ■
OF RAT IgE RESPONSES
Introduction
The IgE antibody response induced in Hooded Lister rats 
by administration of antigen and adjuvant may subsequently 
be enhanced either specifically by further exposure to antigen 
(Jarrettand Stewart ,1974) or non-specifically by infection 
with the helminth parasite Nippostrongylus brasiliensis (Orr 
and Blair, 1969 j Jarrett and Stewart, 1972 and reviewed by 
Jarrett, 1976). In the latter case the enhanced response is 
associated with a great increase in total serum IgE.
In this laboratory for many years the 'potentiated1 
reagin response was elicited consistenly by N. brasiliensis 
infection in rats which had been primed with EA and B. pertussis. 
Latterly, however, the response had become more elusive and 
often failed to reach the expected levels although we had not 
knowingly changed our experimental conditions. When all 
other components of the system had been examined I considered 
the possibility that some unknown variation of the B. pertussis 
adjuvant between batches, while not having an obvious effect on 
the primary response, might nevertheless influence the process 
of potentiation. For this reason I tested B. pertussis from 
different sources and also other kinds of adjuvant for their 
effect at the level of the enhanced response. It was found
that the adjuvant used to prime rats does indeed determine 
the occurrence and level of both potentiated and booster 
IgE responses, and moreover that adjuvants clearly 
discriminate between the two types of enhanced response.
Additionally, I have examined the effect of 
Concanavalin A on the IgE response to egg-albumin.
Gollapudi and Kind (1975) showed that Concanavalin A 
could function as an. adjuvant for IgE production against 
egg-albumin in mice if it was injected either in a mixture 
with, or immediately after, the antigen. We wished to see 
if it had similar adjuvant properties in the rat and also 
whether it subsequently augmented the response in the same 
way as N. brasiliensis infection if given alone some time 
after initial immunisation.
Materials and Methods
Antigen/Adjuvant preparations for initial immunisation
Solutions of egg-albumin (EA) (Sigma Grade V) or keyhole 
limpet haemocyanin (KLH) (Calbiochem A grade) were prepared 
in 0.15 M saline. The antigen dose was injected with one of 
the following adjuvants:
B. pertussis (preparations of phase 1 heat killed organisms)
A. From the Institute Pasteur (Production), 'Perthydral' 
vaccine, alum absorbed.
B. From the Wellcome Research Laboratories, Beckenham, 
Kent, a preparation of alum absorbed B. pertussis, 
and
C. the same batch in simple suspension (experimental 
batch VL4769) both kindly donated by Dr. W.H. Foster.
D. From Wellcome Biological Reagents Ltd., standard 
commercial preparation of B. pertussis in simple 
suspension (batch K0173).
E. From the Department of Microbiology, the University 
of Glasgow, a simple suspension of heat killed 
bacteria kindly provided by Professor A. Wardlav;.
EA in saline was mixed with B. pertussis suspension
immediately before use, and each animal was injected intra- 
peri toneally with 0.6 ml of the mixture containing the 
antigen dose and 10^° B. pertussis.
Aluminium hydroxide adjuvant (a £(0H)^) was prepared from 
aluminium sulphate and sodium hydroxide according to the 
method of Herbert (1973). 250 ml of 5 per cent aluminium
sulphate was added to 100 ml of 5 per cent sodium hydroxide 
with vigorous stirring. The resultant precipitate was 
washed twice by centrifugation and decantation and then re­
suspended in 0.15 M saline to the original volume.
'The antigen was absorbed by mixing equal volumes of 
antigen solution and suspension of aluminium salt so that
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the antigen dose was contained in 0.2 ml of the mixture.
The mixture was incubated at room temperature for approximately 
1 hour, and a dose of 0.2 ml was then adminis.tered to rats by 
intraperitoneal injection.
Complete Freund's Adjuvant (CFA) was purchased from Miles 
Laboratories. EA in saline and CFA were mixed in the 
proportions 1:2 and an emulsion was prepared with a 
Silverson homogeniser. Rats were immunised by intra­
muscular injection of 0.2 ml of the emulsion into the 
hind leg.
Concanavalin A (Con A) was purchased from Pharmacia 
(Great Britain) Ltd. The antigen solution was mixed 
in equal volumes with an 8 mg/ml solution of Con A in
2.5 M saline and the mixture was incubated at 37°C for
30 minutes. Rats were immunised by the intraperitoneal
injection of 0.1 ml of the mixture containing 400 |ig 
Con A and the desired antigen dose.
Procedures for enhancing the primary IgE responses
a) Booster dose of antigen - in the experiments described 
here, this was always 1 |ig EA injected intraperitoneally 
without adjuvant.
b) N. brasiliensis infection - rats were infected by sub­
cutaneous injection of 4000 N. brasiliensis larvae. A
culture of N. brasiliensis is maintained in this 
laboratory by repeated sub-inoculation in Hooded Lister
rats. The method of culture and infection of rats 
was as follows. Faecal pellets (containing parasite 
eggs) were collected from rats with a 7-10 day old 
infection. The pellets were moistened and spread 
on to filter paper circles which were placed on 
pieces of moist sponge in petri dishes. The dishes 
were placed in a humid incubator at 27°C for 4-5 
days during which time the eggs hatch. The larvae 
were then harvested by adding water at 37°C to the 
petri dishes. The water was filtered under suction on 
to course filter paper on which the larvae are 
retained. This filter paper was then inverted on 
an Endecott sieve (mesh 400) in a Baerman apparatus 
filled with water at 37°C. The larvae which swim 
through the sieve were run off after sedimentation.
The larvae in aliquots of suspension were counted 
and the suspension was adjusted to contain 4000 
larvae/ml. Rats were infected by injecting 4000
larvae subcutaneously in the flank region.
c) Con A - 400 Jig in 2.5 M saline was injected intra-
peritoneally.
Statistical analysis
Antibody levels from more than 2 groups were compared
by analysis of variance. Students T test was used to
compare antibody levels of one group with another. All 
tests were carried out at a significance level of 
p <0.05.
All other materials and methods have already been 
described previously in this thesis.
Results
Effect of adjuvant used in initial immunisation on 
enhanced IgE responses brought about by a booster 
dose of antigen or N. brasiliensis infection
Three groups of 10 rats were primed with 10 jig EA 
together with one of the adjuvants B. pertussis (preparation 
D in Materials and Methods), hi(OH) or CFA. One month 
later, each of the three groups was sub-divided into two, 
whereupon 5 rats were given a booster of 1 )ig EA and the 
other 5 were infected with N. brasiliensis.
Table 7 shows the EA PCA titres 12 days after initial 
immunisation and 4 and 12 days after antigen challenge or 
N . brasiliensis infection respectively.
The difference between the primary IgE response of 
rats immunised with B. pertussis, a £(0H)^ or CFA, was not 
statistically significant, i.e. analysis of variance 
indicated that the three groups could be regarded as having 
come_from identical populations. The enhanced responses 
however segregated into two distinct patterns, namely high 
level booster response associated with poor potentiated
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response in the B. pertussis group, and conversely poor 
to absent booster response associated with high level 
potentiated response in the a£(OH)^ and CFA groups. For 
both types of enhanced response, analysis of variance of 
the three groups showed that they originated from 
separate populations.
In order to test for variation of enhancing effects 
following priming with antigen and different preparations 
of B. pertussis, I carried out the experiment outlined 
in Table 8. Here, 5 groups of 10 rats were primed with 
10 jig EA together with one of the five B. pertussis 
suspensions described in the Materials and Methods.
Again, one month after immunisation each group was sub­
divided into two, and the rats of each sub-group were 
either given a further injection of 1 jug EA or were 
infected with N. brasiliensis. The results (Table 8) 
show that the primary IgE response of the rats primed 
with alum absorbed B. pertussis suspensions (A and B) 
were somewhat higher than those of the groups primed 
with B. pertussis in simple suspension, and this difference 
in level was statistically significant. The experiment 
also showed that priming with alum absorbed B. pertussis 
led eventually to the best potentiated response but that 
no elevation occurred following a booster dose of antigen.
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The results of both above experiments indicated 
that the inclusion of a£(OH)^ in the priming event 
prepared the animals well for potentiation of the response 
by subsequent N. brasiliensis infection, but inhibited 
subsequent antigen stimulated booster responses. Since 
this effect apparently occurred whether a£(OH)^ w as 
absorbed to EA or to B. pertussis we considered the 
possibility that the a £(OH)^ per se might influence the 
response. However, in experiments in which a£(OH)^ was 
administered by itself either one week before or 
simultaneously with but not absorbed to EA and B. pertussis 
it was not found to influence either the potentiated or 
booster response.
Since the occurrence of booster IgE antibody responses 
following immunisation of Hooded Lister rats with EA and 
B. pertussis is largely inhibited if the priming dose of 
antigen is greater than 10 \iq (Jarrett and Stewart, 1974) , 
we considered the possibility that the inhibition of booster 
responses following immunisation with EA-a£(0H)_ might be 
the result of more effective utilisation of the EA dose so 
that 'large dose suppression1 might be induced by priming 
with, a comparatively smaller amount of antigen. Consequently,
I  immunised groups of rats with 20, 2, 0.2 and 0.02 \ig EA 
in a£(0H) and challenged with 10 ng EA one month later. A 
primary response occurred in the first two groups (20 and 2 p.g) .
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This response was not increased but rather diminished 
following challenge. The smaller doses of EA did not 
result either in primary responses or booster responses 
following antigen challenge.
Con A as an adjuvant and an enhancing agent for the 
IgE response to EA and KLH_________________________
To determine if Con A could function as an adjuvant 
for the induction of an IgE response to EA or as an agent 
for the subsequent enhancement of the IgE response, two 
groups of rats were immunised with 100 \ig EA and B. pertussis 
(E) or 100 |ug EA and Con A respectively as described in the 
Materials and Methods. One month later the rats of both 
groups were injected with 400 |_Lg Con A and were bled 4 and 
12 days later.
The results (Table 9) showed that Con A had an adjuvant 
effect for the induction of an IgE response to EA in rats.
The response induced with Con A as adjuvant was significantly 
greater than that of the rats immunised with EA and B. pertussis. 
Con A injected alone one month after priming also had an 
enhancing effect on the already existing EA IgE response 
induced with B. pertussis or with Con A as adjuvant. The 
Con A enhanced response occurred by day 4 after Con A injection, 
and had declined again to low levels by day 12. in this 
respect the Con A response resembles the booster response 
elicited by challenge with antigen and differs from the
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enhanced response stimulated by N. brasiliensis infection 
which reaches a peak 12-14 days after infection. I also 
measured the levels of total serum IgE before and after 
the enhancing injection of Con A and found that total IgE 
was not significantly increased by administration of this 
agent. This again is in contrast to enhancement brought 
about by N. brasiliensis which is accompanied by a great 
increase in total IgE (Jarrett and Bazin, 1974).
In order to test if the adjuvant effect of Con A was 
restricted to the EA IgE response, I repeated the above 
experiment using instead keyhole limpet haemocyanin as 
antigen. I found that Con A did not act as an adjuvant 
for the induction of a response to KLH, nor did it enhance 
the IgE response to KLH induced by immunisation with this 
antigen and B. pertussis.
Finally, I show here the results of an experiment to 
compare the Con A and N. brasiliensis enhanced IgE responses 
following immunisation with the various adjuvants used in 
this study. Four groups of 10 rats were immunised with 10 
fig EA given with B. pertussis, Con A, a £.(0H)^ or CFA 
respectively. One month later each group of rats was divided 
into two and the 5 rats of each subgroup were either given 
Con A or were infected with N. brasiliensis. Table 10 shows 
that the Con A enhancing effect occurred only in the animals 
initially immunised with B. pertussis or Con A as adjuvants
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and not at all in those immunised with a £(OH) or CFA. Conversely,3
a potentiated response only occurred in the aZ(OK) and CFA 
immunised animals and not in these immunised with B. pertussis 
or Con A.
DISCUSSION
The production of IgE antibody involves the proliferation 
and maturation of IgE B cells under the influence of helper and 
suppressor T cells in turn influenced by the products of other 
types (Tada, 1976; Ishizaka, 1976; Bourne et al., 1974). Clearly, 
the system offers numerous points of access to intervention by 
adj uvants.
Adjuvants are usually used in conjunction with antigen in 
order to facilitate the induction of an immune response and IgE 
responses in particular cannot usually be induced unless adjuvant 
is used. The adjuvants which have been most commonly used for 
this purpose are a £(OH)^/ B. pertussis and CFA (Mota, 1964; 
Revoltella and Ovary, 1969; Levine and Vaz, 1970; Strannegard 
and Chan, 1969; Kishimoto and Ishizaka, 1973; and reviewed by 
Tada 1975).
Adjuvants used to induce specific responses may function 
by increasing and prolonging the effect of antigen dose, by
enhancing the interaction of B cells with antigen, by expanding
helper .T cell populations or abrogating the effect of suppressor
cells and by stimulating the processing of antigen by macrophages
which may indirectly lead to the above effects (Freund, 1956;
Dresser and Phillips, 1973; Unanue et al., 1969; Hamaoka and 
Katz, 1973; Allison and Davies, 1971; Tada e t a l ., 1972;
WHO Technical Report 595, 1976). These effects may occur 
singly or in combination depending on a complexity of 
variables including the individual antigen and the manner 
of its use, the dose and form of antigen, and the nature 
of the test system and species.
Infection of the rat with live helminth parasites 
has a rather different and restricted stimulating effect: 
it is selective for IgE and is capable of non-specifically 
enhancing only already existing IgE antibody responses.
Thus, parasites cannot assist in the priming of an IgE 
response to heterologous antigen administered at or around 
the time of infection. In order for a response to be 
potentiated it must first be induced by immunisation with 
the antigen and one of the conventional adjuvants (Orr and 
Blair, 3.969 ; Jarrett et al. , 1972) . Evidently the 
potentiating effect of parasites is exerted directly or 
indirectly on primed IgE B cells.
Some time ago however we began to realise that the 
mere induction of a primary IgE response was not a sufficient 
prerequisite for its subsequent potentiation. This is amply 
borne out in the results of these experiments which show 
that while the IgE responses to EA induced with B. pertussis, 
a£(o h) or CFA are of a similar level, potentiated responses 
following infection occur more consistently and to a higher 
level in animals immunised with the aid of the latter two 
adjuvants.
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In a similar way the state of readiness of the rats 
to produce an antigen driven booster IgE response cannot 
be prejudged from the level of the primary response. It 
has previously been shown that although primary IgE 
responses of Hooded Lister rats immunised in the dose 
range of 1 fig - 1 mg EA (with B. pertussis) cannot be 
distinguished, booster responses can subsequently be 
elicited only in animals initially immunised with the 
lower doses of antigen (Jarrett and Stewart, 1974).
As can be seen from the experiments reported here the 
booster response is quite variable, not only between 
individua] animals, but also between experiments. We 
have been unable to relate this variability to different 
batches of B. pertussis (with the exceptions discussed below) or 
antigen and can at present only suppose that it results 
from variable environmental or physiological host factors 
which influence the balance in expression between helper 
and suppressor mechanisms.
Clearly, factors other than the dose of antigen used 
in initial immunisation can affect this balance. Here it 
is shown that booster IgE responses cannot be evoked in 
rats primed even with a small amount of antigen if the 
adjuvant used in the priming event is a£(OH)^ or CFA.
These adjuvants thus have an effect, not evident in terms 
of the amount of antibody produced in the primary response,
which prepares the immune system more effectively than 
B. pertussis for potentiation of the response by parasites 
and for suppression of the booster response following 
reactivation by antigen. Perhaps the most straightforward 
explanation for this combination of effects is that a£(OH)^ 
and CFA by comparison with B. pertussis lead to further 
rounds of proliferation of both memory B cells and memory 
T cells. In this way a second dose of antigen could 
reactivate an enlarged suppressor T cell population to a 
position of predominance in the booster response. Parasitic 
infection would lead to an enhanced potentiated response 
through trie evailability of a larger EA specific B cell pool 
on which to act through antigen non-specific mechanisms.
The problem of the declining efficacy of B. pertussis 
in producing potentiable IgE responses has not really been 
solved. It has however been found that the absorption of 
B. pertussis to a£(OH)^ increases its efficacy in this 
respect, and also that initial immunisation with B. pertussis 
in this form, by comparison with a simple suspension leads 
to the complete suppression of booster responses. The 
observation that a£.(OH)^ had a similar effect whether 
absorbed to EA or to B. pertussis suggested it might per se 
influence the immune responses. Walls (1977) has shown that 
the injection of a£(OH)^ causes an eosinophil response in mice
in the absence of specific antigen stimulation and that 
this response is T cell dependent. However, in an 
experiment here in which a£(OH)^ was injected intra­
muscularly in rats immunised simultaneously with EA and 
B. pertussis intraperitoneally it did not have any 
detectable influence on primary or subsequent enhanced 
IgE responses.
B. pertussis has two adjuvant principles and each 
acts on several cell types involved in the immune response. 
The heat labile lymphocytosis promoting/histamine 
sensitising factors (Morse and Morse, 1976; Lehrer et al., 
1975) is a potent adjuvant for haemagglutinating and 
reaginic antibody in rats and mice (Clausen et al., 1969;
Tada et al., 1972; Lehrer et al., 1976). The bacterial 
lipopolysacharide (LPS) has also been shown to be an 
adjuvant for the induction of an IgE response in mice 
(Newburger et al., 1974; Danneman and Michael, 1976) and 
is thought to be the main active component for IgE adjuvant 
activity in guinea pigs (Mota et al., 1974). LPS is a B 
cell mitogen in vitro (Janossy and Greaves, 1971; Anderson 
et al., 1972) but its adjuvant activity in vivo is not solely 
dependent on this property (Newburger et al., 1974; Ness 
et al., 1976).
It is possible that the relative proportions of 
these two adjuvants in a given B. pertussis preparation 
could influence the degree of stimulation of one cell 
type relative to another, and that the proportions could 
be influenced by perhaps quite minor changes in culture 
and processing techniques. It would be interesting to 
investigate this possibility in the model described here.
Con A, a selective T cell mitogen (Anderson et al. ,
1972) can either stimulate or inhibit immune responses 
probably through the activation of helper or suppressor 
T cells respectively (Dutton, 1972; Rich and Pierce,
1973; Markham et al. , 1977; Nirmal et al. , 1972; Egan 
et al. , 1974; Romball and Weigle, 1975). Gollapudi and 
Kind (1975) showed that Con A could act as an adjuvant 
for the induction of an IgS response to EA in mice and 
further that pre-immunisation with Con A alone could prime 
mice to EA so that higher levels of IgE to EA were produced 
on subsequent immunisation with EA alone (Gollapudi and 
Kind, 1977). The explanations put forward for this second 
phenomenon include the possibility that EA and Con A cross- 
re act at the T cell level and indeed the Con A enhancing 
effect was not found to apply to the antigens human or 
bovine serum albumin or normal rabbit serum. Here I have 
shown that Con A can function as an adjuvant for the induction 
of an IgE response to EA in the rat and also that a subsequent
injection of Con A alone will enhance the response to 
EA.
By contrast with the enhanced response produced 
by parasites the Con A response has the characteristics 
of a booster response. Both antigen and Con A enhanced 
responses occur 4 days after injection of antigen or 
Con A respectively. Both responses occur only in animals 
initially immunised with EA together with B. pertussis 
or Con A and are inhibited in rats immunised with EA in 
a£(OH) or CFA. The potentiated response, on the other 
hand, reaches a peak 12-14 days after N. brasiliensis 
infection, and occurs most strikingly j.n rats initially 
immunised with EA in At(OH)^ or CFA. The potentiated 
response is associated with a great increase in total 
serum IgE whereas this increases by at most 2-3 p.g/ml 
during the booster and Con A responses.
These findings are compatible with the idea of cross­
reaction of Con A and EA at the T cell level, more so 
since we have found that Con A functions neither as 
adjuvant nor enhancing agent fcr the IgE response to 
KLH. The evidence that mouse T and B cells recognise 
different determinants on the EA molecule (Takatsu and 
Ishizaka, 1975) is interesting in this context.
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Another possibility for a Con A enhancing effect on 
IgE production is through the non-specific activation of 
T lymphocytes which however would be expected to influence 
the KLH response. Alternatively, by its activity as an 
IgE-airected ligand (Magro and Bennich, 1977) there is a 
possibility that Con A might cause direct activation of 
IgE B cells. This however would be expected to influence 
the level of total circulating IgE.
The experiments reported here were done initially to 
overcome a practical problem and were not therefore designed 
to answer questions about the mechanism of adjuvant action.
They do however help to explain discrepancies between 
laboratories in occurrence of the potentiated IgE response 
following N. brasiliensis infection, and also they exemplify 
the importance of initial adjuvant in the elicitation of 
subsequent IgE booster responses. These experiments illustrate 
very clearly the stimulation of different combinations of 
cell types, or difference in degree of stimulation of one 
cell type relative to others by the different adjuvants 
used and the system clearly offers unusual scope for further 
investigation of the mechanism of adjuvant action.
3. IgE PRODUCTION IN DIFFERENT RAT STRAINS
Introduction
From the literature on the IgE response in rats, it 
would seem that Hooded Lister rats by comparison with other 
rat strains are exceptionally good IgE producers. However, 
in most of the previous studies, rats were immunised with a 
large amount of antigen which, as we now know, is inhibitory 
to the production of booster responses even in Hooded Lister 
rats. Levine and Vaz (1970) showed that mouse strains could 
be segregated into poor or good IgE antibody producers 
according to their response to immunisation with a small 
dose of antigen. Similar although rather more limited 
studies in rats have been reported by Murphey et al. , (1974). 
From their studies, it emerged that Brown Norway rats 
responded to immunisation with 1 \ig EA in a£.(0H)^ with a 
prolonged IgE response similar to that which is seen in 
Hooded Listers, other rat strains (AC1 and F344) did not 
respond. Booster responses did not occur to any extent 
in any of the strains which these authors studied. However, 
a£(0H)^ was used as the adjuvant in their immunisations 
and as was shown in the previous section this adjuvant, 
while being effective in the induction of rat IgE antibody, 
causes effective suppression of booster responses.
Smith and Petillo (1976) have reported that the 
potentiated IgE response to egg-albumin following 
infection of rats with N, brasiliensis is more marked 
in some rat strains than others. Again, Brown Norway 
rats were shown to be good responders.
In order to confirm, and enlarge on, these findings 
a number of different strains have been examined here 
for their ability to produce booster and potentiated 
responses to EA following immunisation with a high or 
low dose of the antigen and B. pertussis adjuvant.
Materials and Methods 
Rats
CFHB and CFY rats were purchased from Anglia Laboratory 
Animals Ltd., Hooded Lister (HL) iats from Animal Suppliers 
(London) Ltd., and Sprague Dawley (SD) rats from Olac 
Northern Ltd. The Albino Swiss (AS), Brown Norway (BN) 
and hybrid AS/BN rats were donated by the Animal House of 
the Western Infirmary, Glasgow. All other materials and 
methods have been previously described.
Results 
Experiment 1
This experiment involved groups of 10 rats of the 
strains SD, CFHB, CFY and HL. Each group was divided 
into two sub-groups of 5. Rats of sub-group A were
immunised with 1 mg EA and of sub-group B with 1 jig 
EA in each case injected in saline solution intra- 
peri toneally with 1010 B. pertussis as adjuvant.
Twenty four days later, all rats were challenged 
with 1 jig EA given intraperitoneally without adjuvant 
and 34 days after this (i.e. 58 days after immunisation) 
by which time the booster response is known to have 
declined (Jarrett and Stewart, 1974), all the rats were 
infected with 4000 N. brasiliensis larvae. The rats 
were bled 12 days after immunisation, 4 days after 
antigen challenge and 12 days after N. brasiliensis 
infection.
The resultant IgE antibody levels to EA are shown 
in Table 11 and Fig. 4. In the Sprague Dawley group, 
a few animals only responded to immunisation with either 
1 mg or 1 Jig EA. Nevertheless, booster responses 
occurred in 4/5 animals of both groups A and B following 
the booster dose of antigen. However, subsequent 
parasitic infection was without effect at all, and in 
fact 12 days after infection, EA IgE antibodies were 
indetectable in the serum.
Both CFHB and CFY strains performed rather better. 
Primary responses occurred in both strains following 
immunisation with 1 mg of EA. 1 jig EA induced a response
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in 3/5 CFHB rats, but was sub-threshold for rats of 
the CFY strain. Booster responses however occurred 
even in previously negative animals, and in the CFHB 
strain rats at least were consistently higher level 
in group B initially immunised with 1 fig EA. In both 
strains the potentiated response varied considerably 
between individual animals, occurring rather more 
frequently in the CFY rats.
Hooded Lister rats included as a control group, 
performed more or less as expected, with a primary 
response to each of the doses of antigen, booster 
responses much higher in group B and potentiation 
occurring in both groups regardless of size of initial 
immunising dose.
Experiment 2
This experiment involved groups of AS, BN and AS/BN 
cross rats. The rats were immunised with 10 fig EA and
1010 B. pertussis and were challenged 2 3 days later with 
1 fig EA. Thirteen days after this, the animals were 
infected with 4000 N. brasiliensis larvae. Table 12 and 
Fig. 5 show the EA IgE antibody levels 12 days after 
immunisation, 4 days after antigen challenge and 12 days 
after infection. Clearly, the BN rats responded to all 
three stimuli with a greater EA IgE antibody response 
than the other groups. AS rats responded poorly to both 
primary and booster immunisations and did not produce a
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The IgE response of Albino Swiss (AS), Brown 
Norway (BN) and AS/BN cross rats to immunisation 
with egg-albumin and subsequent egg-albumin 
challenge and N. brasiliensis infection.
potentiated response following N. brasiliensis infection.
The responses of the AS/BN rats were interesting in that 
IgE production was intermediate during both primary and 
booster responses, but after N. brasiliensis infection 
absence of response was dominant.
Total serum IgE following N. brasiliensis infection
Total serum IgE levels were measured after N. brasiliensis 
infection on pooled serum samples from Experiment 1, and 
individual sera from Experiment 2. The results are shown 
in Table 13 from which it can be seen that a great measure 
of variation exists among the different strains in the 
extent to which parasitic infection causes an increase in 
total IgE levels. Also, it can be seen that the total 
serum IgE level in AS/BN rats is intermediate between AS 
having very low response and BN which have a very high 
response.
Discussion
These experiments have demonstrated strain differences 
for reaginic antibody production in the rat. The effects 
of a large immunising dose and a small immunising dose 
given with B. pertussis and their effect on subsequent 
challenge and infection have been examined.
TABLE 13. Total serum IgE in different rat strains 
12 days after N. brasiliensis infection.
Strain ' p.g/ml Total IgE
SD AB
20.5 
20.1
CFHB
A
B
21.4
20.4
CFY AB
100
118
HL
A
B
160
121
AS 2.3 ± 0.45
AS/BN 20.1 ± 3.74
BN 171 ± 23.2
*Mean ± Standard Error.
102
Sprague Dawley rats responded poorly to 1 mg and 
1 jig of EA but did produce low level secondary responses.
In CFHB and Hooded Lister rats, the secondary responses 
were higher after initial immunisation with 1 jig EA.
CFY produced similar but low level secondary responses 
after both initial immunising doses even although a 
primary response was not detected after 1 jig.
As was discussed in the Introduction to this section, 
it is now known that suppressor and helper T cells play
O
an important role in the IgE responsiveness of mice and 
rats. There are antigen-specific helper and suppressor 
T cells which respectively enhance and suppress IgE 
response to specific antigen (Tada and Okumura, 1971; 
Ishizaka, 1976; Tada, 1976). Recently, a second population 
of antigen non-specific suppressor T cells has been 
described, whose action is apparently to prevent the 
induction of all IgE antibody responses (Watanabe et al♦, 
1976; Chiorazzi et al., 1977).
Hooded Lister and Brown Norway rats by comparison 
with the other 'poor IgE producing' strains used here 
are either deficient in this latter population of cells 
or in a mechanism influencing their expression. The 
antigen-specific suppressive mechanism is however activated 
following immunisation with a large dose of antigen and
is thought to cause the inhibitory effect on booster 
IgE responses. It is likely that the other rat strains 
examined here possess more active versions of both 
suppressive mechanisms.
It is interesting in this context, that the 
lymphocytes of Brown Norway rats have been found to 
respond less vigorously than those of Lewis rats to 
the T cell mitogens phytohaemagglutinin and concanavalin 
A (Newlin and Gasser, 1973; Williams et al. , 1973) .
Thus, the incorporation of tritiated thymidene was 
much lower in Brown Norway lymph node cells following 
stimulation of cell cultures with the above mitogens.
These results reflected a difference between the two 
strains either in relative numbers of reactive T cells 
or in their ability to divide as a result of influences 
from other cell types. It is interesting also that 
elevation of total serum IgE occurred after infection 
in the poor responder strains of rat, even where the 
potentiated response was absent. An interesting feature 
of the AS/BN hybrid rat, is that the IgE levels after 
N . brasiliensis infection, are intermediate between 
those of the parent strains, neither of the characteristics 
of the parent strains, i.e. high level/BN nor low level/AS, 
being obviously dominant.
It seeins probable that the total serum IgE produced 
in infection is related directly to the basal serum IgE 
level which also varies considerably among different rat 
strains (Bennich et al., 1976). Similar strain dependent 
differences in rat total IgE before and after Schistosoma 
mansoni infection have been demonstrated by Rousseaux- 
Prevost et al., (1977).
It is clear that the variation in IgE response seen 
in the different rat strains following conventional 
immunisation or helminth infection reflects quantitative 
or qualitative differences in the components of the IgE 
regulatory network. The preliminary experiments reported 
here will be extended in an attempt to obtain a clearer 
understanding of the immunoreguiatory effect.
REFERENCES
Allison, A .C . and Davies, A.J.S. (1971). Nature, 233, 330.
Anderson, J.,Moller, G. and Sjoberg, 0. (1972). Cellular
Immunol., 4_, 381.
Augustin, R. (1967). "Handbook of Experimental Immunology", 
Ed. D.M. Weir. Blackwell, Oxford, p. 42.
Avrameas, . s.  and Ternynck, T. (1969). Immunochemistry,
£, 5 .
Barth, E.E.E., Jarrett, W.F.H. and Urquhart, G.M. (1966). 
Immunology, 10_, 459.
Bazaral, M. , Orgel, Alice and Hamburger, R.N. (1973). Clin. 
Exp. Immunol., _14, 117.
Bazin, H., Beckers, A., Deckers, C. and Moriame, M. (1973).
J. Natn. Cancer Inst., 5JL, 1351.
Bennich, H. and Dorrington, K. (1973). "Biological Role of 
the Immunoglobulin E System", Eds. K. Ishizaka and D.H. 
Dayton. Nat. Inst, of Chid. Hlth. and Human Dev.,
Bethseda, Maryland, p.19.
Bennich, H. and Johansson, S.G.O. (1968). "Gammaglobulins", 
Ed. K. Killander. Wiley Interscicnce, New York, p.199.
Bennich, H. and Johansson, S.G.O. (1971). Adv. Immunol.,
13, 1.
Bennich, H., Ishizaka, K., Johansson, S.G.O., Rowe, D.S., 
Stanworth, D.R. and Terry, W.H. (1968). Bull. Wld. Hlth. 
Org., £8, 51.
Bennich, H., Johansson, S.G.O., Von-Bahr-Lmdstrom, H. and 
Karlsson, T. (1976). "Molecular and Biological Aspects 
of the Acute Allergic Reaction." Eds. S.G.O. Johansson,
K. Strandberg and B. Uvnas. Plenum, New York, p.175.
Berg, T. and Johansson, S.G.O. (1969a). Int. Arch. Allergy 
and Applied Immunol., 36 ,219.
Berg, T. and Johansson, S.G.O. (1969b). Acts. Paediat. Scand. 
58, 513.
Berglund, G., Finnstrom, 0., Johansson, S.G.O. and Moller, K.L 
(1968). Acta. Paediat. Scand., 57, 89.
Bernstein, I.D. and Ovary, Z„ (1968). Int. Arch. Allergy,
33, 521.
Bienstock, J. (1974). "Progress in Immunology II", Vol. 4. 
Eds. L. Brent and J. Holborrow. p.197.
Binaghi, R.A. and Benacerraf, B. (1964). J. Immunol., 92, 
920.
Binaghi, R.A., Benacerraf, B., Bloch, K. and Kourilsky, F. 
(1964). J. Immunol., 92_, 927.
Blackeley, C.H. (1893). Experimental Researches on the 
causes and nature of Catarrhus aestivus (hay fever or 
hay asthma). Dawsonsvof Pall Mall, London.
Bourne,, H.R., Lichenstein, L.M., Melman, K.L., Henney, C.S., 
Weinstein, Y. and Shearer, G.M. (1974). Science, 184, 19.
Brocklehurst, W.E. (1973). "Handbook of Experimental 
Immunology". Ed. D.M. Weir. Blackwell, Oxford, p.21.
Ceska, M. and Lundkvist, U. (1972) . Immunochemistry, 9_, 
1021.
Chiorazzi, N., Fox, D.A. and Katz, D.H. (1977). J. Immunol., 
118, 48.
Clausen, C.R., Munoz, J. and Bergmam, R. (1969). J. Immunol'., 
103, 768.
Coca, A.F. and Grove, E.F. (1925). J. Immunol. , 1£, 445.
Conrad, D.H., Bazin, H., Sehon, A.H. and Froese, A. (1975). 
J. Immunol., 114, 1688.
Coombs, R.A., Howard, A.N. and Mynors, L.S. (1953). Brit. J. 
Exp. Path., 34_, 525.
Coombs, R.A., Hunter, A., Jonas, W.E., Bennich, H., Johansson,. 
S.G.O. and Panzani, R. (1968). Lancet i, 115.
Crabbe, P.A., Nash, D.R., Bazin, H., Eysson, H. and Heremans, 
J.F. (1969). J. Exp. Med., 130, 723.
Dale, H.H. (1913). J. Pharmacol., 4_, 167.
Danneman, Pamela J. and Micheal, J.G. (1976). Cellular Immunol. 
22, 128.
Dresser, D.W. and Phillips,J.M.(1973) . "Immunopotentiation, 
Ciba Foundation Symposium No. 18". Elsevier, Amsterdam, 
p. 3.
Dutton, R.W. (1972). J. Exp. Med., 136, 1445.
Egan, H.S., Reeder, W.J. and Ekstedt, R.D. (1974). J. Immunol 
_m, 63.
Franklin, E.C. (1964). Prog. Allergy, 8, 58.
Freund, J. (1956). Adv. Tuberc. Res., 7_, 130.
Gleich, G.J., Averbeck, A.K. and Swedlund, H.A. (1971).
J. Lab. Clin. Med., 77_, 690.
Gleich, G.J. and Jacob, G.L. (1975). Science, 190, 1106.
Gollapudi, U.S.S. and Kind, L.S. (1975). Int. Arch. Allergy, 
48, 94.
Gollapudi, U.S.S. and Kind, L.S. (1977). Int. Arch. Allergy, 
5_3, 569.
Goodfriend, L., Kovacs, B.A. and Rose, B. (1966). J. Allergy 
37, 122,
Greenwood, F.C., Hunter, W.M. and Glover, J.S. (1963).
Biochem. J,, 89_, 114.
Hamaoka, T. and Katz, D.H. (1973). J. Immunol., 111, 1554.
Herbert, W.J. (1973). "Handbook of Experimental Immunology". 
Ed. D.M. Weir. Blackwell, Oxford, Appendix 2.
Heremans, J.F. (1969). Nat. Inst. Chid. Hlth. and Human Dev., 
Bethseda, Maryland, p.309.
Heremans, J.F. and Vaerman, I.P., (1962). Nature, 193, 1091.
Hoffman, D.R., Yamamoto, F.Y., Geller, B. and Haddad, Z. 
(1975). J. Allergy Clin. Immunol., 55, 256.
Hogarth-Scott, R.S., Johansson, S.G.O. and Bennich, H. (1969). 
Clin. Exp. Immunol., 5_, 617.
Huldt, G., Johansson, S.G.O. and Lantto, S. (1973). Arch. 
Environ. Hlth., 26, 36.
Ishizaka, K. (1976). "Molecular and Biological Aspects of 
the Acute Allergic Reaction". Eds. S.G.O. Johansson,
K. Strandberg and B. Uvnas. Plenum, New York, p.59.
Ishizaka, K. and Ishizaka, T. (1968c). J. Immunol., 101,
68.
Ishizaka, K. and Ishizaka, T. (1971). "Biochemistry of 
the Acute Allergic Reaction". Eds. K.F. Austin and 
E.L. Becker. Blackwell, Oxford, p.13.
Ishizaka, K., Ishizaka, T. and Hornbrock, M.M. (1966b).
J. Immunol., 9_7_, 75.
Ishizaka, K. , Ishizaka, T. and Hornbrook, M.M. (1966c).
J. Immunol., 97_, 840.'
Ishizaka, K., Ishizaka, T. and Lee, E.H. (1966a).
J. Immunol., 37_, 336.
Ishizaka, K., Ishizaka, T. and Menzel, A.E.O. (1967).
J. Immunol., 99_, 610.
Ishizaka, K., Ishizaka, T. and Terry, W. (1967c).
J. Immunol., 99_, 849.
Ishizaka, K. and Okudaira, H. (1972). J. Immunol., 109,
84.
Ishizaka, T., Soto, C. and Ishizaka, K. (1972b). J. Immunol 
109, 1290.
Ishizaka, T., Soto, C. and Ishizaka, K. (1973). J. Immunol. 
Ill, No. 2, 500.
Ishizaka, K., Tomioka, H. and Ishizaka, T. (1970).
J. Immunol., 105, No. 6, 1459.
Janossy, G. and Greaves, M.F. (1971). Clin. Exp. Immunol., 
9_, 483.
Jarrett, E.E.E. (1976). "Molecular and Biological Aspects 
of the Acute Allergic Reaction". Eds. S.G.O. Johansson, 
K. Strandberg and B. Uvnas. Plenum, New York, p.105.
Jarrett, E.E.E. and Bazin, H. (1974). Nature, 251, 613.
Jarrett, E.E.E., Henderson, D. Riley, P. and White, R.G. 
(1972). Int. Arch. Allergy, 42_, 475.
110
Jarrett, E.E.E. , Orr, T.S.C. and Riley, P. (1971). Clin.
Exp. Immunol. , 9_, 585.
Jarrett, E.E.E. and Stewart, D. (1972). Immunology, 23,
749.
Jarrett, E.E.E. and Stewart, D. (1974). Immunology, 27,
365.
Jarrett, E.E.E., Jarrett, W.F.H. and Urquhart, G.M. (1968a). 
Parasitology, 58_, 625.
Johansson, S.G.O. (1967). Lancet ii, 951.
Johansson, S.G.O. (1968a). Int. Arch. Allergy, 34, 1.
Johansson, S.G.O. and Bennich, H. (1967), Immunology, 1_3,
381.
Johansson, S.G.O., Bennich, II. and Wide, L. (1968). Immunology, 
14, 265.
Johansson, S.G.O., Mellbin, T. and Vahlquist, B. (1968c).
Lancet i, 11.18.
Kishimoto, T. and Ishizaka, K. (1973). J. Immunol., Ill,
1194.
Korenblatt, P.E., Rothberg, R.m */ Minden, P. and Farr, R.S. 
(1968). J. Allergy, 4_!1, 226.
Korotzer, J.L., Haddad, Z.II. and Lopapa , A.F. (1971).
• Immunology, 20_, 245.
Lehrer, S.B., Vaughan, J.H. and Tan, E  .N. (1975). J. Immunol., 
114, 34.
Lehrer, S.B., Vaughan, J.H. ana Tan, E.N. (1976). J. Immunol., 
116, 178.
Levine, B. and Vaz, N.M. (1.970). Int. Arch. Allergy, 39^ , 156.
Lindstrom von-Bahr, H. and Bennich, H. (1974). FEBS letters,
40, 57.
Magro, A.M. and Bennich, H. (1977) . Immunology, 33_, 51.
Mancini, G., Carbonara, A.O. and Hereman, J.F. (1965).
Immunochemistry, 2, 235.
Mann, D. , Granger, H. and Fahey, J.L. (1969) . J. Immunol., 
102, 618.
Markham, P., Reed, N.D., Stashak, P.W., Prestcott, B., 
Amsbaugh, D.F. and Baher, P.J. (1977). J. Immunol., 
119, 1163.
McDougall, W.A. (1974). B.Sc., Honours Thesis, Faculty 
of Science, University of Glasgow.
McLaughlin, P., Stanworth, D.R., Kennedy, J.F. and Cho Tun, 
H. (1971). Nature (New Biol.), 232, 245.
Miller, H.R.P. and Jarrett, W.F.H. (1971). Immunology,
20, 277.
Morgan, C.R. and Lazerow, A. (1963). Diabetes, 12_, 115.
Morse, S. I. and Morse, J.H. (1976). J. Exp. Med., 143,
1483.
Mota, I. (1964). Immunology, 1_, 681.
Mota, I. (1967) . Immunology, 12_, 343.
Mota, I., Perini, A. and Truidale, V. S. (1974). Int. Arch.
Allergy, £7, 425.
Murphey, S.H., Brown, S., Miklos, N. and Fireman, P. (1974). 
Immunology, 21_, 245.
Murray,. M. (1972). "Immunity to Animal Parasites". Ed.
E.J.L. Soulsby. Academic Press, p.155.
Ness, D.B., Smith, S., Talcott, J.A. and Gruner, F.C. (1976). 
Eur. J. Immunol., 6_, 650.
Newburger, P.E., Hamaoka, T. and Katz, D.H. (1974). J. Exp. 
Med., 113, 824.
Newlin, C. and Gasser, D. (1973). J. Immunol., 110, No. 3, 622
Nirmul, G., Severin, C. and Taub, R.N. (1972). Transplantation 
L4, 91.
Ogawa, M., Berger, P.A., McIntyre, O.R., Glendinning, W.E. and 
Ishizaka, K. (1971). Arch. Dermatol., 103, 575.
Ogawa, M., Kochwa, S., Smith, C., Ishizaka, K. and McIntyre, 
O.R. (1969). New Eng. J. Med., 281, 1217.
112
Ogilvie, B. (1967). Immunology, 12_, 113.
Okumura, K. and Tada, T. (1974). J. Immunol., 112, 783.
Orr, T.S.C. and Blair, A.M.J. (1969). Life Sciences, 8, n,  
1077.
Oudin, J. (1946). Complete Rend. Ac. Sci., 222, 115.
Ovary, Z. (1952). Int. Arch. Allergy and Applied Immunol.,
_3, 293.
Ovary, Z. (1964). "Immunological Methods Cloms Symposium5'.
Ed. J.F. Ackroyd. Blackwell, Oxford, p.259.
Ovary, Z. (1965) . Fed.' Proc. , 24_, 94.
Parkins, R.A., Dimitriadou, A. and Booth, C.C. (1960).
Clin. Sci., 19_, 595.
Perelmutter, L., Liakopoulou, A. and Phills, J.A. (1973). 
"Mechanisms in Allergy". Eds. L. Goodfriend, A. Sehon 
and R.P. Orange. Marcel Decker Inc., New York, p.235.
Polmar, S.H., Waldmann, T.A. and Terry, W.D. (1973).
J. Immunol., 110, 1253.
Prausnitz, C. and Kustner, H. (1921). Zbl. Bact. I. Abt. 
Orig. , 86_, 160.
Revoltella, R. and Ovary, Z. (1969). Immunology, 17_, 45.
Rich, R.R. and Pierce, C.W. (1973). J. Exp. Med., 137, 649.
Rorriball, C.G. and Weigle, W.O. (1975). J. Immunol., 115, 
556.
Rosenberg, E.B., Whalen, G.E., Bennich, H. and Johansson, 
S.G.O. (1971). New Eng. J. Med., 283, 1148.
Rousseaux-Prevost, R., Bazin, H. and Capron, A. (1977). 
Immunology, 33_, 501.
Rowe, D.S. (1969). Bull. Wld. Hlth. Org., 40, 613.
Rowe, D.S., Tackett, L., Bennich, H. , Ishizaka, K., Johansson, 
S.G.O. and Anderson, S.G. (1970). Bull. Wld. Hlth. Org.,
43, 609.
Salmon, S.E., Mackey, G. and Fudenberg, H.H. (1969).
J. Immunol., .103, 129.
Sanyal, R.J. and West, G.B. (1958). J. Physiol. (London), 
142, 571.
Smith, S.R. andPertillo, j (1976). Int. Arch. Allergy,
52, 21.
Stanworth, D.R. (1973). "The Molecular Basis of the 
Allergic Response."
Stanworth, D.R., Humphrey, J.H., Bennich, H. and Johansson, 
S.G.O. (1968). Lancet ii, 17.
Stanworth, D.R. and Kuhns, W.J. (1965). Immunology, 8_,
323.
Stechsculte, D.J., Orange, R.P. and Austen, K.F. (1970).
J. Immunol., 105, 1083.
Stewart, D.F. (1953). Aust. J. Agric. Res., 4_, 100.
Strannagard, 0. and Belin, L. (1970). Immunology, 18_, 775.
Strannegard, 0. and Chan, P.C.Y. (1969). J. Allergy, 43, 
224.
Tada, T. (1975). Prog, in Allergy, 19_, 122.
Tada, T. (1976). "Molecular and Biological Aspects of the 
Acute Allergic Reaction". Eds. S.G.O. Johansson,
K. Strandberg and B. Uvnas. Plenum, New York, p.79.
Tada, T. and Ishizaka, K. (1970). J. Immunol., 104, 377.
Tada, T„ and Okumura, K. (1971). J. Immunol., 106, 1002.
Tada, T. and Okumura, K. (1971). J. Immunol., 107, 1137.
Tada, T., Okumura, K. and Iwara, S. (1972). Int. Arch. 
Allergy, 43, 207.
Takatsu, K. and Ishizaka, K. (1975). Cellular Immunol.,
20, 276.
Taylor, B., Norman, A.F., Orgel, H.A., Stokes, C.R., Turner, 
M.W. and Soothill, J.F. (1973). Lancet ii, 111.
Waldmann, T.A. (1969). New Eng. J. Med., 281, 1170.
Walls, R.S. (1977). Proc. Soc. Exp. Biol.,Med., 156, 
431.
Watanabe, N., Kojirna, S. and Ovary, Z. (1976). J. Exp. 
Med., 143, 833.
W.H.O. Technical Report 595 (1976) . Immunological 
Adjuvants. World Hlth Org., Geneva.
Wide, L., Bennich, H. and Johansson, S.G.O. (1967). 
Lancet ii, 1105.
Wide, L. and Porath, J. (1966). Biochem, Biophys, Acta. 
130, 257.
Williams, R.M., Moore, 14.J. and Benacerraf, B. (1973). 
J. Immunol., Ill, No. 5, 1571.
Unanue, E.R., Askonas, B.A. and Allison, A.C. (1969). 
J. Immunol., 103, 71.
Urquhart, G.M., Mulligan, W., Eadie, R.M. and Jennings,
F.W. (1965). Exp. Parasitol., 17_. 210.
Vaz, N.M. andLevine,B.(1970) . Sciences, 168, 852.
